![]() ![]() | PACHCHEK, S.* , LANDOULSI, Z.* , PAVELKA, L., Schulte, C., Buena-Atienza, E., Gross, C., Hauser, A.-K., Reddy Bobbili, D., Casadei, N., MAY, P.* , KRÜGER, R.* , & NCER-PD Consortium. (23 November 2023). Accurate long-read sequencing identified GBA1 as major risk factor in the Luxembourgish Parkinson's study. NPJ Parkinson's Disease, 9 (1), 156. doi:10.1038/s41531-023-00595-w ![]() * These authors have contributed equally to this work. |
![]() ![]() | HANFF, A.-M., PAULY, C., PAULY, L., RAUSCHENBERGER, A., LEIST, A., KRÜGER, R., Zeegers, M. P.* , McCrum, C.* , & NCER-PD consortium. (23 November 2023). Determinants of patient-reported functional mobility in people with Parkinson's disease: A systematic review. Gait and Posture, 108, 97 - 109. doi:10.1016/j.gaitpost.2023.11.013 ![]() * These authors have contributed equally to this work. |
![]() ![]() | HANFF, A.-M., McCrum, C., RAUSCHENBERGER, A., Aguayo, G., PAULY, C., JONSDOTTIR, S., TSURKALENKO, O., Zeegers, M., LEIST, A., & KRÜGER, R. (2023). Sex-specific progression of Parkinson’s disease: A longitudinal mixed-models analysis. OSF Preprint. doi:10.31219/osf.io/f64zv |
Klee, M., Aho, V., May, P., Heintz-Buschart, A., Landoulsi, Z., Jonsdottir, S., Pauly, C., Pavelka, L., Delacour, L., Kaysen, A., Krüger, R., Wilmes, P., Leist, A., & NCER-PD Consortium. (November 2023). Education as risk factor of Mild Cognitive Impairment - the role of the gut microbiome. Presentation in symposium: Social determinants of brain health: From the search for mechanisms to recommendations to increase equity [Paper presentation]. Annual Meeting of the Gerontological Society of America. |
![]() ![]() | Sosero, Y. L., Bandres-Ciga, S., Ferwerda, B., Tocino, M. T. P., Belloso, D. R., Gómez-Garre, P., Faouzi, J., Taba, P., PAVELKA, L., Marques, T. M., GOMES, C., KOLODKIN, A., MAY, P., Milanowski, L. M., Wszolek, Z. K., Uitti, R. J., Heutink, P., van Hilten, J. J., Simon, D. K., ... Gan-Or, Z. (2023). Dopamine pathway and Parkinson's risk variants are associated with levodopa-induced dyskinesia. ORBilu-University of Luxembourg. https://orbilu.uni.lu/handle/10993/57440. doi:10.1101/2023.08.28.23294610 |
![]() ![]() | Yu, E., Krohn, L., Ruskey, J. A., Asayesh, F., Spiegelman, D., Shah, Z., Chia, R., Arnulf, I., Hu, M. T. M., Montplaisir, J. Y., Gagnon, J.-F., Desautels, A., Dauvilliers, Y., Gigli, G. L., Valente, M., Janes, F., Bernardini, A., Högl, B., Stefani, A., ... Gan-Or, Z. (04 July 2023). HLA in isolated REM sleep behavior disorder and Lewy body dementia. Annals of Clinical and Translational Neurology, 10 (9), 1682-1687. doi:10.1002/acn3.51841 ![]() |
Klee, M., Aho, V., May, P., Heintz-Buschart, A., Landoulsi, Z., Jonsdottir, S., Pauly, C., Pavelka, L., Delacour, L., Kaysen, A., Krüger, R., Wilmes, P., Leist, A., & NCER-PD Consortium, (Other coll.). (July 2023). Education as risk factor of Mild Cognitive Impairment - the role of the gut microbiome [Poster presentation]. Alzheimer’s Association (AAIC) Conference. |
![]() ![]() | Arena, G., Landoulsi, Z., Grossmann, D., Vitali, A., Delcambre, S., Baron, A., Antony, P., Boussaad, I., Bobbili, D. R., Sreelatha, A. A. K., Pavelka, L., Klein, C., Seibler, P., Glaab, E., Sharma, M., Krüger, R., May, P., & Grünewald, A. (2023). Polygenic risk scores validated in patient-derived cells stratify for mitochondrial subtypes of Parkinson\textquoterights disease 2023.05.12.23289877. ORBilu-University of Luxembourg. https://orbilu.uni.lu/handle/10993/55367. doi:10.1101/2023.05.12.23289877 |
![]() ![]() | Kaivola, K., Chia, R., Ding, J., Rasheed, M., Fujita, M., Menon, V., Walton, R. L., Collins, R. L., Billingsley, K., Brand, H., Talkowski, M., Zhao, X., Dewan, R., Stark, A., Ray, A., Solaiman, S., Alvarez Jerez, P., Malik, L., Dawson, T. M., ... Zinman, L. (2023). Genome-wide structural variant analysis identifies risk loci for non-Alzheimer’s dementias. Cell Genomics, 100316. doi:10.1016/j.xgen.2023.100316 ![]() |
![]() ![]() | Peiris, S., Landoulsi, Z., Pavelka, L., Schulte, C., Buena-Atienza, E., Gross, C., Hauser, A.-K., Bobbili, D. R., Casadei, N., May, P., Krüger, R., & Consortium, T. N.-P. (2023). Accurate long-read sequencing identified GBA variants as a major genetic risk factor in the Luxembourg Parkinson\textquoterights study 2023.03.29.23287880. ORBilu-University of Luxembourg. https://orbilu.uni.lu/handle/10993/55244. doi:10.1101/2023.03.29.23287880 |
![]() ![]() | de Nies, L., Galata, V., Martin-Gallausiaux, C., Despotovic, M., Busi, S. B., Snoeck, C. J., Delacour, L., Budagavi, D. P., Laczny, C. C., Habier, J., Lupu, P.-C., Halder, R., Fritz, J. V., Marques, T., Sandt, E., O'Sullivan, M. P., Ghosh, S., Satagopam, V., Consortium, C.-V., ... Wilmes, P. (09 March 2023). Altered infective competence of the human gut microbiome in COVID-19. Microbiome, 11 (1), 46. doi:10.1186/s40168-023-01472-7 ![]() |
![]() ![]() | Sugier, P.-E., Lucotte, E. A., Domenighetti, C., Law, M. H., Iles, M. M., Brown, K., Amos, C., McKay, J. D., Hung, R. J., Karimi, M., Bacq-Daian, D., Boland-Augé, A., Olaso, R., Deleuze, J.-F., Lesueur, F., Ostroumova, E., Kesminiene, A., de Vathaire, F., Guénel, P., ... Elbaz, A. (14 February 2023). Investigation of Shared Genetic Risk Factors Between Parkinson's Disease and Cancers. Movement Disorders, n/a (n/a). doi:10.1002/mds.29337 ![]() |
![]() ![]() | Vollstedt, E.-J., Schaake, S., Lohmann, K., Padmanabhan, S., Brice, A., Lesage, S., Tesson, C., Vidailhet, M., Wurster, I., Hentati, F., Mirelman, A., Giladi, N., Karen, M., Waters, C., Fahn, S., Kasten, M., Brüggemann, N., Borsche, M., Foroud, T., ... Zimprich, A. (24 January 2023). Embracing Monogenic Parkinson's Disease: The MJFF Global Genetic PD Cohort. Movement Disorders, 38 (2), 286--303. doi:10.1002/mds.29288 ![]() |
![]() ![]() | Chemla, A., Arena, G., Saraiva, C., Berenguer-Escuder, C., Grossmann, D., Grünewald, A., Klein, C., Seibler, P., Schwamborn, J. C., & Krüger, R. (2023). Generation of two induced pluripotent stem cell lines and the corresponding isogenic controls from Parkinson's disease patients carrying the heterozygous mutations c.1290A > G (p.T351A) or c.2067A > G (p.T610A) in the RHOT1 gene encoding Miro1. Stem Cell Research, 69, 103085. doi:10.1016/j.scr.2023.103085 ![]() |
![]() ![]() | Chemla, A., Arena, G., Onal, G., Walter, J., Berenguer-Escuder, C., Grossmann, D., Grünewald, A., Schwamborn, J. C., & Krüger, R. (2023). Generation of two induced pluripotent stem cell lines and the corresponding isogenic controls from Parkinson’s disease patients carrying the heterozygous mutations c.815G>A (p.R272Q) or c.1348C>T (p.R450C) in the RHOT1 gene encoding Miro1. Stem Cell Research, 103145. doi:10.1016/j.scr.2023.103145 ![]() |
![]() ![]() | Hanff, A.-M., McCrum, C., Rauschenberger, A., Aguayo, G. A., Zeegers, M. P., Leist, A., & Krüger, R. (2023). Validation of a Parkinson's disease questionnaire-39-based functional mobility composite score (FMCS) in people with Parkinson's disease. Parkinsonism & related disorders, 112, 105442. doi:10.1016/j.parkreldis.2023.105442 ![]() |
Klee, M., Aho, V., May, P., Krüger, R., Wilmes, P., Leist, A., & NCER-PD Consortium (Other coll.). (January 2023). Education as risk factor of Mild Cognitive Impairment - the role of the gut microbiome [Poster presentation]. Conference Precision Medicine in Parkinson’s: Past lessons and conquering new frontiers. |
![]() ![]() | Cheng, F., Zheng, W., Liu, C., Barbuti, P. A., Yu-Taeger, L., Casadei, N., Huebener-Schmid, J., Admard, J., Boldt, K., Junger, K., Ueffing, M., Houlden, H., Sharma, M., Krüger, R., Grundmann-Hauser, K., Ott, T., & Riess, O. (23 November 2022). Intronic enhancers of the human SNCA gene predominantly regulate its expression in brain in vivo. Science Advances, 8 (47), 6324. doi:10.1126/sciadv.abq6324 ![]() |
![]() ![]() | Vega Moreno, C. G., Gawron, P., Lebioda, J., Groues, V., Krüger, R., Schneider, R., & Satagopam, V. (20 September 2022). SMASCH: Facilitating multi-appointment scheduling in longitudinal clinical research studies and care programs [Poster presentation]. European Conference on Computational Biology, Sitges, Spain. doi:10.5281/zenodo.6832272 |
![]() ![]() | Meyrath, M., Szpakowska, M., Plesseria, J.-M., Domingues, O., Langlet, J., Weber, B., Krüger, R., Ollert, M., & Chevigné, A. (09 September 2022). Nanoluciferase-based cell fusion assay for rapid and high-throughput assessment of SARS-CoV-2-neutralizing antibodies in patient samples. Methods in Enzymology, 675, 351-381. doi:10.1016/bs.mie.2022.07.015 ![]() |
![]() ![]() | Weiss, D., Landoulsi, Z., May, P., Sharma, M., Schüpbach, M., You, H., Corvol, J. C., Paschen, S., Helmers, A.-K., Barbe, M., Fink, G., Kühn, A. A., Courbon, C. B., Wojtecki, L., Damier, P., Fraix, V., Houeto, J.-L., Regis, J., Sixel-Döring, F., ... Krüger, R. (2022). Genetic stratification of motor and QoL outcomes in Parkinson's disease in the EARLYSTIM study. Parkinsonism and Related Disorders. doi:10.1016/J.PARKRELDIS.2022.08.025 ![]() |
![]() ![]() | Pauly, L., Hansen, M., Pauly, C., Leist, A., & Krüger, R. (September 2022). PRELIMINARY RESULTS ON THE COGNITIVE PROFILE IN PRODROMAL PARKINSON’S DISEASE – A PROSPECTIVE STUDY [Poster presentation]. Movement Disorders Society Congress 2022. |
![]() ![]() | Ray, A., Reho, P., Shah, Z., International LBD Genomics Consortium, May, P., Krüger, R., & Scholz, S. W. (2022). Evaluation of SORL1 in Lewy Body Dementia Identifies No Significant Associations. Movement Disorders. doi:10.1002/mds.29207 ![]() |
![]() ![]() | Mahoney-Sanchez, L., Bouchaoui, H., Boussaad, I., Jonneaux, A., Timmerman, K., Berdeaux, O., Ayton, S., Krüger, R., Duce, J. A., Devos, D., & Devedjian, J.-C. (23 August 2022). Alpha synuclein determines ferroptosis sensitivity in dopaminergic neurons via modulation of ether-phospholipid membrane composition. Cell Reports, 40 (8), 111231. doi:10.1016/j.celrep.2022.111231 ![]() |
![]() ![]() | Capelle, C., Cire, S., Hansen, M., Pavelka, L., Hedin, F., Konstantinou, M., Revets, D., Tslaf, V., Marques, T., Baron, A., Domingues, O., Zeng, N., May, P., Cosma, A., Balling, R., Krüger, R., Ollert, M., & He, F. (2022). Early-to-mid idiopathic Parkinson’s disease shows a more cytotoxic but declined CD8-regulatory peripheral immune profile. ORBilu-University of Luxembourg. https://orbilu.uni.lu/handle/10993/51989. doi:10.21203/rs.3.rs-1834770/v1 |
![]() ![]() | Reho, P., Koga, S., Shah, Z., Chia, R., Krüger, R., May, P., Consortium, T. I. L. B. D. G., Center, T. A. G., Rademakers, R., Dalgard, C. L., Boeve, B. F., Beach, T. G., Dickson, D. W., Ross, O. A., & Scholz, S. W. (2022). GRN Mutations Are Associated with Lewy Body Dementia. Movement Disorders. doi:10.1002/mds.29144 ![]() |
![]() ![]() | Domenighetti, C., Douillard, V., Sugier, P.-E., Sreelatha, A. A. K., Schulte, C., Grover, S., May, P., Bobbili, D. R., Radivojkov-Blagojevic, M., Lichtner, P., Singleton, A. B., Hernandez, D. G., Edsall, C., Gourraud, P.-A., Mellick, G. D., Zimprich, A., Pirker, W., Rogaeva, E., Lang, A. E., ... Consortium, E. I. P. S. D. C.-P. D. (2022). The Interaction between HLA-DRB1 and Smoking in Parkinson's Disease Revisited. Movement Disorders. doi:10.1002/mds.29133 ![]() |
![]() ![]() | Höglinger, G., Schulte, C., Jost, W. H., Storch, A., Woitalla, D., Krüger, R., Falkenburger, B., & Brockmann, K. (31 May 2022). GBA-associated PD: chances and obstacles for targeted treatment strategies. Journal of neural transmission (Vienna, Austria : 1996), 129 (9), 1219-1233. doi:10.1007/s00702-022-02511-7 ![]() |
![]() ![]() | Grover, S., Ashwin, A. K. S., Pihlstrom, L., Domenighetti, C., Schulte, C., Sugier, P.-E., Radivojkov-Blagojevic, M., Lichtner, P., Mohamed, O., Portugal, B., Landoulsi, Z., May, P., Bobbili, D. R., Edsall, C., Bartusch, F., Hanussek, M., Krüger, J., Hernandez, D. G., Blauwendraat, C., ... consortium, E. I. P. T. D. C.-P. D. (2022). Genome-wide Association and Meta-analysis of Age-at-Onset in Parkinson Disease: Evidence From COURAGE-PD Consortium 10.1212/WNL.0000000000200699. Neurology. doi:10.1212/WNL.0000000000200699 ![]() |
![]() ![]() | Danileviciute, E., Zeng, N., Capelle, C. M., Paczia, N., Gillespie, M. A., Kurniawan, H., Benzarti, M., Merz, M. P., Coowar, D., Fritah, S., Vogt Weisenhorn, D. M., Gomez Giro, G., Grusdat, M., Baron, A., Guerin, C., Franchina, D. G., Léonard, C., Domingues, O., Delhalle, S., ... He, F. (26 May 2022). PARK7/DJ-1 promotes pyruvate dehydrogenase activity and maintains T(reg) homeostasis during ageing. Nature Metabolism, 4 (5), 589-607. doi:10.1038/s42255-022-00576-y ![]() |
![]() ![]() | Liu, H., Dehestani, M., Blauwendraat, C., Makarious, M. B., Leonard, H., Kim, J. J., Schulte, C., Noyce, A., Jacobs, B. M., Foote, I., Sharma, M., International Parkinson's Disease Genomics Consortium, Comprehensive Unbiased Risk Factor Assessment For Environment in Parkinson's Disease Consortium, Landoulsi, Z., Krüger, R., May, P., Bobbili, D. R., Pavelka, L., Nalls, M., Singleton, A., ... Bandres-Ciga, S. (2022). Polygenic Resilience Modulates the Penetrance of Parkinson Disease Genetic Risk Factors. Annals of Neurology. doi:10.1002/ana.26416 ![]() |
![]() ![]() | Pauly, L., Klee, M., Paccoud, I., Satagopam, V., Ghosh, S., Fritz, J., O'Sullivan, M., Wilmes, P., Krüger, R., & Leist, A. (April 2022). Individual factors and beliefs determining COVID-19 vaccination willingness [Poster presentation]. ECCMID 2022. |
![]() ![]() | Pauly, L., Pauly, C., Hansen, M., Schröder, V., Rauschenberger, A., Leist, A., & Krüger, R. (2022). Retrograde Procedural Memory in Parkinson’s Disease: A Cross-Sectional, Case-Control Study. Journal of Parkinson's Disease. doi:10.3233/JPD-213081 ![]() |
![]() ![]() | Pauly, L., Pauly, C., Hansen, M., Schröder, V., Rauschenberger, A., Leist, A., & Krüger, R. (March 2022). Retrograde Procedural Memory in Parkinson's Disease [Poster presentation]. Deutscher Kongress für Parkinson und Bewegungsstörungen 2022. doi:10.3233/JPD-213081 |
![]() ![]() | Langer, A., Lucke-Paulig, L., Gassner, L., Krüger, R., Weiss, D., Gharabaghi, A., Zach, H., Maetzler, W., & Hobert, M. A. (2022). Additive Effect of Dopaminergic Medication on Gait Under Single and Dual-Tasking Is Greater Than of Deep Brain Stimulation in Advanced Parkinson Disease With Long-duration Deep Brain Stimulation. Neuromodulation : journal of the International Neuromodulation Society. doi:10.1016/j.neurom.2022.01.015 ![]() |
![]() ![]() | Domenighetti, C., Sugier, P.-E., Ashok Kumar Sreelatha, A., Schulte, C., Grover, S., Mohamed, O., Portugal, B., May, P., Bobbili, D. R., Radivojkov-Blagojevic, M., Lichtner, P., Singleton, A. B., Hernandez, D. G., Edsall, C., Mellick, G. D., Zimprich, A., Pirker, W., Rogaeva, E., Lang, A. E., ... Consortium, E. I. P. S. D. C.-P. D. (2022). Dairy Intake and Parkinson's Disease: A Mendelian Randomization Study. Movement Disorders. doi:10.1002/mds.28902 ![]() |
![]() ![]() | Cheng, F., Zheng, W., Barbuti, P. A., Bonsi, P., Liu, C., Casadei, N., Ponterio, G., Meringolo, M., Admard, J., Dording, C. M., Yu-Taeger, L., Nguyen, H. P., Grundmann-Hauser, K., Ott, T., Houlden, H., Pisani, A., Krüger, R., & Riess, O. (07 January 2022). DYT6 mutated THAP1 is a cell type dependent regulator of the SP1 family. Brain: a Journal of Neurology, 145 (11), 3968-3984. doi:DOI:10.1093/brain/awac001 ![]() |
![]() ![]() | Brunelli, F., Torosantucci, L., Gelmetti, V., Franzone, D., Grünewald, A., Krüger, R., Arena, G., & Valente, E. M. (2022). PINK1 Protects against Staurosporine-Induced Apoptosis by Interacting with Beclin1 and Impairing Its Pro-Apoptotic Cleavage. Cells, 11 (4). doi:10.3390/cells11040678 ![]() |
![]() ![]() | Vega Moreno, C. G., Gawron, P., Lebioda, J., Groues, V., Matyjaszczyk, P., Pauly, C., Smula, E., Krüger, R., Schneider, R., & Satagopam, V. (2022). Smart Scheduling (SMASCH): multi-appointment scheduling system for longitudinal clinical research studies. JAMIA Open, 5 (2), 038. doi:10.1093/jamiaopen/ooac038 ![]() |
![]() ![]() | Pauly, C., Glaab, E., Hansen, M., Martin-Gallausiaux, C., Ledda, M., Marques, T., Wilmes, P., Krüger, R., & Consortium, N.-P. (2022). Parkinson's Disease progression, resilience and inflammation markers during the COVID-19 pandemic. Movement Disorders, in press (doi: 10.1002/mds.29212) (in press). doi:10.1002/mds.29212 ![]() |
![]() ![]() | Pavelka, L., Rauschenberger, A., Landoulsi, Z., Pachchek, S., Marques, T., Gomes, C., Glaab, E., May, P., Krüger, R., & NCER-PD, C. (2022). Body-First Subtype of Parkinson's Disease with Probable REM-Sleep Behavior Disorder Is Associated with Non-Motor Dominant Phenotype. Journal of Parkinson's Disease. doi:10.3233/JPD-223511 ![]() |
![]() ![]() | Pavelka, L., Rauschenberger, A., Landoulsi, Z., Pachchek, S., May, P., Glaab, E., NCER-PD, C., & Krüger, R. (Other coll.). (2022). Age at onset as stratifier in idiopathic Parkinson's disease - effect of ageing and polygenic risk score on clinical phenotypes. NPJ Parkinson's Disease, 9 (8), 102. doi:10.1038/s41531-022-00342-7 ![]() |
![]() ![]() | Fründt, O., Hanff, A.-M., Mai, T., Kirchner, C., Bouzanne des Mazery, E., Amouzandeh, A., Buhmann, C., Krüger, R., & Südmeyer, M. (2022). Impact of COVID-19 Pandemic on (Health) Care Situation of People with Parkinson’s Disease in Germany (Care4PD). Brain Sciences, 12 (1 62). doi:10.3390/brainsci12010062 ![]() |
![]() ![]() | Zeng, N.* , Capelle, C. M.* , Baron, A., Kobayashi, T., Cire, S., Tslaf, V., Leonard, C., Coowar, D., Koseki, H., Westendorf, A. M., Buer, J., Brenner, D., Krüger, R., Balling, R., Ollert, M., & He, F. (2022). DJ‐1 depletion prevents immunoaging in T‐cell compartments. EMBO Reports, 23 (3). doi:10.15252/embr.202153302 ![]() * These authors have contributed equally to this work. |
![]() ![]() | Arena, G., Sharma, K., Agyeah, G., Krüger, R., Grünewald, A., & Fitzgerald, J. C. (2022). Neurodegeneration and Neuroinflammation in Parkinson’s Disease: a Self-Sustained Loop. Current Neurology and Neuroscience Reports, 22 (8), 427 – 440. doi:10.1007/s11910-022-01207-5 ![]() |
![]() ![]() | Bowring, F., Welch, J., Woodward, C., Lo, C., Lawton, M., Sulzer, P., Hanff, A.-M., Krüger, R., Liepelt-Scarfone, I., & Hu, M. T. (2022). Exploration of whether socioeconomic factors affect the results of priority setting partnerships: updating the top 10 research priorities for the management of Parkinson's in an international setting. BMJ Open, 12 (6), 049530. doi:10.1136/bmjopen-2021-049530 ![]() |
![]() ![]() | Hanff, A.-M., Leist, A., Fritz, J., Pauly, C., Krüger, R., Halek, M., & NCER-PD, C. (2021). Determinants of Self-Stigma in People with Parkinson's Disease: A Mixed Methods Scoping Review. Journal of Parkinson's Disease. doi:10.3233/JPD-212869 ![]() |
![]() ![]() | Leist, A., Klee, M., Paccoud, I., Pauly, L., Ghosh, S., Fritz, J., O Sullivan, M. P., Rommes, B., Wilmes, P., Krüger, R., & CON-VINCE Consortium. (2021). Which demographic and socio-economic factors are associated with vaccination willingness and beliefs towards vaccination? Rapid report with first results. |
![]() ![]() | Barbuti, P. A., Ohnmacht, J., Santos, B. F., Antony, P., Massart, F., Cruciani, G., Dording, C. M., Pavelka, L., Casadei, N., Kwon, Y.-J., & Krüger, R. (09 November 2021). Gene-corrected p.A30P SNCA patient-derived isogenic neurons rescue neuronal branching and function. Scientific Reports, 11, 21946. doi:10.1038/s41598-021-01505-x ![]() |
![]() ![]() | Bremm, R. P., Berthold, C., Krüger, R., Koch, K. P., Goncalves, J., & Hertel, F. (2021). Therapeutic maps for a sensor-based evaluation of deep brain stimulation programming. Biomedizinische Technik. Biomedical Engineering. doi:10.1515/bmt-2020-0210 ![]() |
![]() ![]() | Kaivola, K., Shah, Z., Chia, R., International LBD Genomics Consortium, May, P., Krüger, R., & Scholz, S. W. (25 October 2021). Genetic evaluation of dementia with Lewy bodies implicates distinct disease subgroups. Brain: a Journal of Neurology, awab402. doi:10.1093/brain/awab402 ![]() |
![]() ![]() | Domenighetti, C., Sugier, P. E., Sreelatha, A. A. K., Schulte, C., Grover, S., Mohamed, O., Portugal, B., May, P., Bobbili, D. R., Radivojkov-Blagojevic, M., Lichtner, P., Singleton, A. B., Hernandez, D. G., Edsall, C., Mellick, G. D., Zimprich, A., Pirker, W., Rogaieva, E., Lang, A. E., ... Elbaz, A. (2021). Mendelian randomization study of smoking, alcohol, and coffee drinking in relation to Parkinso's disease. Journal of Parkinson's Disease, 1-16. doi:10.3233/JPD-212851 ![]() |
Leist, A., Wilmes, P., Krüger, R., & NCER-PD Consortium. (2021). Zusammenhänge zwischen sozio-ökonomischem Status und Darmmikrobiom als Risiko für Demenz [Paper presentation]. Journée de Gérontologie, Dommeldange, Luxembourg. |
Bolognin, S., Smits, L., Nickels, S. L., Magni, S., Antony, P., Grzyb, K., Krüger, R., Skupin, A., & Schwamborn, J. C. (2021). A new brain organoid model to study Parkinson’s Disease. Biomedical Science and Engineering. |
![]() ![]() | Pauly, L., Rauschenberger, A., Pauly, C., Hansen, M., Pavelka, L., Hanff, A.-M., Schröder, V., Leist, A., & Krüger, R. (17 September 2021). The retrograde procedural memory in people with Parkinson’s disease with or without freezing of gait – a cross-sectional study [Poster presentation]. Movement Disorders Society Congress 2021. |
![]() ![]() | Ribeiro, F., Schröder, V., Krüger, R., Leist, A., & the CON-VINCE Consortium. (September 2021). The evolution and social determinants of mental health during the first wave of the COVID-19 outbreak in Luxembourg. Psychiatry Research, 303. doi:10.1016/j.psychres.2021.114090 ![]() |
![]() ![]() | Zeng, N., Capelle, C., Baron, A., Cire, S., Leonard, C., Coowar, D., Koseki, H., Westendorf, A., Buer, J., Brenner, D., Krüger, R., Balling, R., Ollert, M., & He, F. (2021). DJ-1 depletion slows down immunoaging in T-cell compartments. bioRxiv. doi:10.1101/2021.05.21.445139 |
![]() ![]() | Krüger, R., The Global Parkinson's Genetics Program, & The Global Parkinson's Genetics Program. (April 2021). GP2: The Global Parkinson's Genetics Program. Movement Disorders, 36 (4), 842-851. doi:10.1002/mds.28494 ![]() |
![]() ![]() | Grover, S., Kumar-Sreelatha, A. A., Bobbili, D. R., May, P., Domenighetti, C., Sugier, P.-E., Schulte, C., COURAGE-PD Consortium, Elbaz, A., Krüger, R., Gasser, T., & Sharma, M. (2021). Replication of a Novel Parkinson's Locus in a European Ancestry Population. Movement Disorders. doi:10.1002/mds.28546 ![]() |
![]() ![]() | Krüger, R., Pavelka, L., Mollenhauer, B., Bloem, B., van Rumund, A., Esselink, R. A. J., Geurtz, B. P. M., Wevers, R. A., & Verbeek, M. M. (2021). Peripheral decarboxylase inhibitors paradoxically induce aromatic L-amino acid decarboxylase. NPJ Parkinson's Disease. doi:10.1038/s41531-021-00172-z ![]() |
![]() ![]() | Krüger, R., Kern, F., Fehlmann, T., Violich, I., Hutchins, E., Alsop, E., Kahraman, M., Grammes, N., Balling, R., Geffers, L., & Keller, A. (2021). Deep sequencing of sncRNAs reveals hallmarks and regulatory modules of the transcriptome during Parkinson’s disease progression. Nature Aging. doi:10.1038/s43587-021-00042-6 ![]() |
![]() ![]() | Chia, R., Sabir, M. S., Bandres-Ciga, S., Saez-Atienzar, S., Reynolds, R. H., Gustavsson, E., Walton, R. L., Ahmed, S., Viollet, C., Ding, J., Makarious, M. B., Diez-Fairen, M., Portley, M. K., Shah, Z., Abramzon, Y., Hernandez, D. G., Blauwendraat, C., Stone, D. J., Eicher, J., ... Scholz, S. W. (2021). Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture. Nature Genetics. doi:10.1038/s41588-021-00785-3 ![]() |
![]() ![]() | Dewan, R., Chia, R., Ding, J., Hickman, R. A., Stein, T. D., Abramzon, Y., Ahmed, S., Sabir, M. S., Portley, M. K., Tucci, A., Ibáñez, K., Shankaracharya, F. N. U., Keagle, P., Rossi, G., Caroppo, P., Tagliavini, F., Waldo, M. L., Johansson, P. M., Nilsson, C. F., ... Traynor, B. J. (03 February 2021). Pathogenic Huntingtin Repeat Expansions in Patients with Frontotemporal Dementia and Amyotrophic Lateral Sclerosis. Neuron, 109 (3), 448-460. doi:10.1016/j.neuron.2020.11.005 ![]() |
![]() ![]() | Mencke, P., Boussaad, I., Romano, C., Kitami, T., Linster, C., & Krüger, R. (2021). The Role of DJ-1 in Cellular Metabolism and Pathophysiological Implications for Parkinson’s Disease. Cells. doi:10.3390/cells10020347 ![]() |
![]() ![]() | Holuka, C., Snoeck, C. J., Mériaux, S. B., Ollert, M., Krüger, R., Turner, J., & The Con-Vince Consortium. (2021). Adverse Life Trajectories Are a Risk Factor for SARS-CoV-2 IgA Seropositivity. Journal of Clinical Medicine, 10 (10). doi:10.3390/jcm10102159 ![]() |
![]() ![]() | Wolf, C., Pouya, A., Bitar, S., Pfeiffer, A., Bueno, D., Arndt, S., Tenzer, S., Dal Bello, F., Vianello, C., Ritz, S., Schwirz, J., Dobrindt, K., Peitz, M., Hanschmann, E.-M., Boussaad, I., Brüstle, O., Giacomello, M., Krüger, R., & Methner, A. (2021). GDAP1 loss of function inhibits the mitochondrial pyruvate dehydrogenase complex by altering the actin cytoskeleton 2021.03.04.433895. ORBilu-University of Luxembourg. https://orbilu.uni.lu/handle/10993/50307. doi:10.1101/2021.03.04.433895 |
![]() ![]() | Brown, S. J., Boussaad, I., Jarazo, J., Fitzgerald, J. C., Antony, P., Keatinge, M., Blechman, J., Schwamborn, J. C., Krüger, R., Placzek, M., & Bandmann, O. (2021). PINK1 deficiency impairs adult neurogenesis of dopaminergic neurons. Scientific Reports. doi:10.1038/s41598-021-84278-7 ![]() |
![]() ![]() | Boussaad, I., Cruciani, G., Bolognin, S., Antony, P., Dording, C., Kwon, Y.-J., Heuting, P., Fava, E., Schwamborn, J. C., & Krüger, R. (2021). Integrated, automated maintenance, expansion and differentiation of 2D and 3D patient-derived cellular models for high throughput drug screening. Scientific Reports. doi:10.1038/s41598-021-81129-3 ![]() |
![]() ![]() | Jarazo, J., Barmpa, K., Modamio, J., Saraiva, C., Sabaté Soler, S., Rosety, I., Griesbeck, A., Skwirblies, F., Zaffaroni, G., Smits, L., Su, J., Arias-Fuenzalida, Walter, J., Gomez Giro, G., Monzel, A., Qing, X., Vitali, A., Cruciani, G., Boussaad, I., ... Schwamborn, J. C. (2021). Parkinson’s disease phenotypes in patient neuronal cultures and brain organoids improved by 2-Hydroxypropyl-b-Cyclodextrin treatment. Movement Disorders. doi:10.1002/mds.28810 ![]() |
![]() ![]() | Pauly, C., Ribeiro, F., Schröder, V., Pauly, L., Krüger, R., & Leist, A. (2021). The Moderating Role of Resilience in the Personality-Mental Health Relationship During the COVID-19 Pandemic. Frontiers in Psychiatry. doi:10.3389/fpsyt.2021.745636 ![]() |
![]() ![]() | Walter, J., Bolognin, S., Poovathingal, S., Magni, S., Gerard, D., Antony, P., Nickels, S. L., Salamanca, L., Berger, E., Smits, L., Grzyb, K., Perfeito, R., Hoel, F., Qing, X., Ohnmacht, J., Bertacchi, M., Jarazo, J., Ignac, T., Monzel, A., ... Schwamborn, J. C. (2021). The Parkinson’s-disease-associated mutation LRRK2-G2019S alters dopaminergic differentiation dynamics via NR2F1. Cell Reports. doi:10.1016/j.celrep.2021.109864 ![]() |
![]() ![]() | Becker, S., Pauly, C., Lawton, M., Hipp, G., Bowring, F., Sulzer, P., Hu, M., Krüger, R., Gasser, T., & Liepelt-Scarfone, I. (2021). Quantifying activities of daily living impairment in Parkinson’s disease using the Functional Activities Questionnaire. Neurological Sciences. doi:10.1007/s10072-021-05365-1 ![]() |
![]() ![]() | Arena, G., & Krüger, R. (2021). Exploring the contribution of the mitochondrial disulfide relay system to Parkinson’s disease: the PINK1/CHCHD4 interplay. Neural Regeneration Research. doi:10.4103/1673-5374.310679 ![]() |
![]() ![]() | Farrer, M. J., Bardien, S., Hattori, N., Lesage, S., Ross, O. A., Mellick, G. D., & Krüger, R. (2021). Editorial: Celebrating the Diversity of Genetic Research to Dissect the Pathogenesis of Parkinson's Disease. Frontiers in Neurology, 12. doi:10.3389/fneur.2021.648417 ![]() |
![]() ![]() | Bremm, R. P., Koch, K. P., Krüger, R., Goncalves, J., & Hertel, F. (26 November 2020). Analysis and visualisation of tremor dynamics in deep brain stimulation patients. Current Directions in Biomedical Engineering, 6 (3), 4. doi:10.1515/cdbme-2020-3030 ![]() |
![]() ![]() | Bremm, R. P., Koch, K. P., Krüger, R., Hertel, F., & Goncalves, J. (26 November 2020). A rule-based expert system for real-time feedback-control in deep brain stimulation. Current Directions in Biomedical Engineering, 6 (3), 4. doi:10.1515/cdbme-2020-3027 ![]() |
![]() ![]() | Fehlmann, T., Lehallier, B., Schaum, N., Hahn, O., Kahraman, M., Li, Y., Grammes, N., Geffers, L., Backes, C., Balling, R., Kern, F., Krüger, R., Lammert, F., Ludwig, N., Meder, B., Fromm, B., Maetzler, W., Berg, D., Brockmann, K., ... Keller, A. (24 November 2020). Common diseases alter the physiological age-related blood microRNA profile. Nature Communications, 11 (1), 5958. doi:10.1038/s41467-020-19665-1 ![]() |
![]() ![]() | Zanin, M., Santos, B. F. R., Antony, P., Berenguer-Escuder, C., Larsen, S. B., Hanss, Z., Barbuti, P., Baumuratov, A., Grossmann, D., Capelle, C. M., Weber, J., Balling, R., Ollert, M., Krüger, R., Diederich, N. J., & He, F. (10 November 2020). Mitochondria interaction networks show altered topological patterns in Parkinson's disease. NPJ Systems Biology and Applications, 6 (1), 38. doi:10.1038/s41540-020-00156-4 ![]() |
![]() ![]() | Hanss, Z., Larsen, S., Antony, P., Mencke, P., Massart, F., Jarazo, J., Schwamborn, J. C., Barbuti, P., Mellick, G., & Krüger, R. (2020). Mitochondrial and Clearance Impairment in p.D620N VPS35 Patient-Derived Neurons. Movement Disorders. doi:10.1002/mds.28365 ![]() |
![]() ![]() | Neumann, M. A.-C.* , Grossmann, D.* , Schimpf-Linzenbold, S., Dayan, D., Stingl, K., Ben-Menachem, R., Pines, O., Massart, F., Delcambre, S., Ghelfi, J., Bohler, J., Strom, T., Kessel, A., Azem, A., Schöls, L., Grünewald, A., Wissinger, B., & Krüger, R. (2020). Haploinsufficiency due to a novel ACO2 deletion causes mitochondrial dysfunction in fibroblasts from a patient with dominant optic nerve atrophy. Scientific Reports. doi:10.1038/s41598-020-73557-4 ![]() * These authors have contributed equally to this work. |
![]() ![]() | Barbuti, P., Santos, B., Dording, C., Cruciani, G., Massart, F., Hummel, A., & Krüger, R. (October 2020). Generation of two iPS cell lines (HIHDNDi001-A and HIHDNDi001-B) from a Parkinson's disease patient carrying the heterozygous p.A30P mutation in SNCA. Stem Cell Research, 48, 101951. doi:10.1016/j.scr.2020.101951 ![]() |
![]() ![]() | Mencke, P., Hanss, Z., Boussaad, I., Sugier, P.-E., Elbaz, A., & Krüger, R. (2020). Bidirectional Relation Between Parkinson’s Disease and Glioblastoma Multiforme. Frontiers in Neurology. doi:10.3389/fneur.2020.00898 ![]() |
![]() ![]() | Chia, R., Sabir, M. S., Bandres-Ciga, S., Saez-Atienzar, S., Reynolds, R. H., Gustavsson, E., Walton, R. L., Ahmed, S., Viollet, C., Ding, J., Makarious, M. B., Diez-Fairen, M., Portley, M. K., Shah, Z., Abramzon, Y., Hernandez, D. G., Blauwendraat, C., Stone, D. J., Eicher, J., ... Scholz, S. W. (2020). Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into the complex genetic architecture. ORBilu-University of Luxembourg. https://orbilu.uni.lu/handle/10993/44713. doi:10.1101/2020.07.06.185066 |
![]() ![]() | Rajan, R., Divya, K. P., Kandadai, R. M., Yadav, R., Satagopam, V., Madhusoodanan, U. K., Agarwal, P., Kumar, N., Ferreira, T., Kumar, H., Sreeram Prasad, A. V., Shetty, K., Mehta, S., Desai, S., Kumar, S., Prashanth, L. K., Bhatt, M., Wadia, P., Ramalingam, S., ... Sharma, M. (18 June 2020). Genetic Architecture of Parkinson's Disease in the Indian Population: Harnessing Genetic Diversity to Address Critical Gaps in Parkinson's Disease Research. Frontiers in Neurology, 11, 524. doi:10.3389/fneur.2020.00524 ![]() |
![]() ![]() | Krüger, R., Baldini, F., Thiele, I., Hertel, J., & NCER-PD Consortium. (2020). Parkinson’s disease-associated alterations of the gut microbiome predict diseaserelevant changes in metabolic functions. BMC Biology. doi:10.1186/s12915-020-00775-7 ![]() |
![]() ![]() | Kern, F., Fehlmann, T., Violich, I., Alsop, E., Hutchins, E., Kahraman, M., Grammes, N. L., Guimarães, P., Backes, C., Poston, K., Casey, B., Balling, R., Geffers, L., Krüger, R., Galasko, D., Mollenhauer, B., Meese, E., Wyss-Coray, T., Craig, D. W., ... Keller, A. (2020). Deep sncRNA-seq of the PPMI cohort to study Parkinson’s disease progression. ORBilu-University of Luxembourg. https://orbilu.uni.lu/handle/10993/44658. doi:10.1101/2020.06.01.127092 |
![]() ![]() | Krüger, R., & Stute, L. (2020). Emerging concepts for precision medicine in Parkinson's disease with focus on genetics. Fortschritte der Neurologie-Psychiatrie. doi:10.1055/a-1149-2204 ![]() |
![]() ![]() | Snoeck, C. J., Vaillant, M., Abdelrahman, T., Satagopam, V., Turner, J., Beaumont, K., Gomes, C., Fritz, J., Schröder, V., Kaysen, A., Pavelka, L., Stute, L., Ramos Meyers, G., Pauly, L., Hansen, M., Pauly, C., Aguayo, G. A., Perquin, M., Hanff, A.-M., ... Krüger, R. (2020). Prevalence of SARS-CoV-2 infection in the Luxembourgish population: the CON-VINCE study. ORBilu-University of Luxembourg. https://orbilu.uni.lu/handle/10993/44961. doi:10.1101/2020.05.11.20092916 |
![]() ![]() | Ohnmacht, J., May, P., Sinkkonen, L., & Krüger, R. (2020). Missing heritability in Parkinson’s disease: the emerging role of non‑coding genetic variation. Journal of Neural Transmission. doi:10.1007/s00702-020-02184-0 ![]() |
![]() ![]() | Larsen, S., Hanss, Z., Cruciani, G., Massart, F., Barbuti, P., Mellick, G., & Krüger, R. (2020). Induced pluripotent stem cell line (LCSBi001-A) derived from a patient with Parkinson's disease carrying the p.D620N mutation in VPS35. Stem Cell Research. doi:10.1016/j.scr.2020.101776 ![]() |
![]() ![]() | Schröder, V., Kaysen, A., Fritz, J., Kemp, J., Wagner, S., Köhler, S., Hartmann, T., Dodel, R., Kalbe, E., Leist, A., & Krüger, R. (April 2020). Programme Démence Prévention (pdp ): A Nation-Wide Programme for Dementia Prevention in Luxembourg [Poster presentation]. Advances in Alzheimer's and Parkinson's Therapies AAT-AD/PD Focus Meeting. |
![]() ![]() | Woitalla, D., Krüger, R., Lorenzl, S., Müller, T., Oelwein, G., Storch, A., Wolz, M., & Wüllner, U. (2020). Grundlagen und Stellenwert der COMT- und MAO-B-Inhibitoren in der Therapie des idiopathischen Parkinson-Syndroms. Fortschritte der Neurologie-Psychiatrie. doi:10.1055/a-1149-9308 ![]() |
![]() ![]() | Fehlmann, T., Kahraman, M., Backes, C., Galata, V., Keller, V., Geffers, L., Mercaldo, N., Hornung, D., Keller, A., Krüger, R., & Balling, R. (2020). Evaluating the Use of Circulating MicroRNA Profiles for Lung Cancer Detection in Symptomatic Patients. JAMA Oncology. doi:10.1001/jamaoncol.2020.0001 ![]() |
![]() ![]() | Bobbili, D. R., Banda, P., Krüger, R., & May, P. (2020). Excess of singleton loss-of-function variants in Parkinson's disease contributes to genetic risk. Journal of Medical Genetics. doi:10.1136/jmedgenet-2019-106316 ![]() |
![]() ![]() | Krüger, R., Balling, R., Antony, P., Kondratyeva, O., Ostaszewski, M., Baumuratov, A., Grossmann, D., Mommaerts, K., Sokolowska, K., Longhino, L., Poulain, J. F., & Diederich, N. J. (2020). Fibroblast mitochondria in idiopathic Parkinson’s disease display morphological changes and enhanced resistance to depolarization. Scientific Reports. doi:10.1038/s41598-020-58505-6 ![]() |
![]() ![]() | Krüger, R., Cheng, F., Walter, M., Riess, O., Wassouf, Z., Hentrich, T., Schulze-Hentrich, J., Barbuti, P., Grundmann-Hauser, K., Ott, T., & Casadei, N. (2020). Unraveling Molecular Mechanisms of THAP1 Missense Mutations in DYT6 Dystonia. Journal of Molecular Neuroscience. doi:10.1007/s12031-020-01490-2 ![]() |
![]() ![]() | Meyrath, M., Szpakowska, M., Zeiner, J., Massotte, L., Merz, M. P., Benkel, T., Simon, K., Ohnmacht, J., Turner, J., Krüger, R., Seutin, V., Ollert, M., Kostenis, E., & Chevigné, A. (2020). The atypical chemokine receptor ACKR3/CXCR7 is a broad-spectrum scavenger for opioid peptides. Nature Communications, 11 (1), 3033. doi:10.1038/s41467-020-16664-0 ![]() |
![]() ![]() | Bus, C., Zizmare, L., Feldkaemper, M., Geisler, S., Zarani, M., Schaedler, A., Klose, F., Admard, J., Mageean, C. J., Arena, G., Fallier-Becker, P., Ugun-Klusek, A., Maruszczak, K. K., Kapolou, K., Schmid, B., Rapaport, D., Ueffing, M., Casadei, N., Krüger, R., ... Fitzgerald, J. C. (2020). Human Dopaminergic Neurons Lacking PINK1 Exhibit Disrupted Dopamine Metabolism Related to Vitamin B6 Co-Factors. iScience, 23 (12), 101797. doi:10.1016/j.isci.2020.101797 ![]() |
![]() ![]() | Grossmann, D., Berenguer-Escuder, C., Chemla, A., Arena, G., & Krüger, R. (2020). The Emerging Role of RHOT1/Miro1 in the Pathogenesis of Parkinson's Disease. Frontiers in Neurology, 11, 587. doi:10.3389/fneur.2020.00587 ![]() |
![]() ![]() | Binck, S., Pauly, C., Vaillant, M., Hipp, G., Gantenbein, M., Krüger, R., & Diederich, N. J. (2020). Contributing Factors and Evolution of Impulse Control Disorder in the Luxembourg Parkinson Cohort. Frontiers in Neurology, 11, 578924. doi:10.3389/fneur.2020.578924 ![]() |
![]() ![]() | Barbuti, P., Antony, P., Rodrigues Santos, B., Massart, F., Cruciani, G., Dording, C., Arias, J., Schwamborn, J. C., & Krüger, R. (2020). Using High-Content Screening to Generate Single-Cell Gene-Corrected Patient-Derived iPS Clones Reveals Excess Alpha-Synuclein with Familial Parkinson's Disease Point Mutation A30P. Cells, 9 (9). doi:10.3390/cells9092065 ![]() |
![]() ![]() | Klucken, J., Winkler, J., Krüger, R., & Jost, W. (2020). Die Geschichte des ‚Freezing-of-gait‘ beim Parkinson-Syndrom – vom Phänomen zum Symptom. Fortschritte der Neurologie-Psychiatrie, 88 (9), 573-581. doi:10.1055/a-1227-6258 ![]() |
![]() ![]() | Berenguer-Escuder, C., Grossmann, D., Antony, P., Arena, G., Wasner, K., Massart, F., Jarazo, J., Walter, J., Schwamborn, J. C., Grünewald, A., & Krüger, R. (2020). Impaired Mitochondrial-Endoplasmic Reticulum Interaction and Mitophagy in Miro1-Mutant Neurons in Parkinson’s Disease. Human Molecular Genetics. doi:10.1093/hmg/ddaa066 ![]() |
![]() ![]() | Monzel, A. S., Hemmer, K., Smits, L., Bolognin, S., Lucarelli, P., Rosety, I., Zagare, A., Antony, P., Nickels, S., Krüger, R., & Schwamborn, J. C. (2020). Machine learning-assisted neurotoxicity prediction in human midbrain organoids. Parkinsonism and Related Disorders. doi:10.1016/j.parkreldis.2020.05.011 ![]() |
![]() ![]() | Hanff, A.-M., Pauly, C., Pauly, L., Schröder, V., Hansen, M., Meyers, G. R., Kaysen, A., Hansen, L., Wauters, F., & Krüger, R. (2020). Unmet Needs of People With Parkinson's Disease and Their Caregivers During COVID-19-Related Confinement: An Explorative Secondary Data Analysis. Frontiers in Neurology, 11, 615172. doi:10.3389/fneur.2020.615172 ![]() |
![]() ![]() | Boussaad, I., Obermaier, C. D., Hanss, Z., Bobbili, D. R., Bolognin, S., Glaab, E., Wołyńska, K., Weisschuh, N., De Conti, L., May, C., Giesert, F., Grossmann, D., Lambert, A., Kirchen, S., Biryukov, M., Burbulla, L. F., Massart, F., Bohler, J., Cruciani, G., ... Krüger, R. (2020). A patient-based model of RNA mis-splicing uncovers treatment targets in Parkinson's disease. Science Translational Medicine, 12 (560). doi:10.1126/scitranslmed.aau3960 ![]() |
![]() ![]() | Berenguer, C., Grossmann, D., Massart, F., Antony, P., Burbulla, L., Glaab, E., Imhoff, S., Trinh, J., Seibler, P., Grünewald, A., & Krüger, R. (2019). Variants in Miro1 cause alterations of ER-mitochondria contact sites in fibroblasts from Parkinson's disease patients. Journal of Clinical Medicine. doi:10.3390/jcm8122226 ![]() |
![]() ![]() | Krüger, R., & Kolber, P. L. (2019). Gene-environment interaction and Mendelian randomisation. Revue Neurologique. doi:10.1016/j.neurol.2019.04.010 ![]() |
![]() ![]() | Simons, J., Vaillant, M., Hipp Epouse D'amico, G., Pavelka, L., Stute, L., Pauly, C., & Krüger, R. (2019). Multilingual Validation of the First French Version of Munich Dysphagia Test-Parkinson's Disease (MDT-PD) in the Luxembourg Parkinson's Study. Frontiers in Neurology. doi:10.3389/fneur.2019.01180 ![]() |
![]() ![]() | Schymanski, E., Baker, N. C., Williams, A. J., Singh, R., Trezzi, J.-P., Kolber, P. L., Wilmes, P., Krüger, R., Paczia, N., Linster, C., & Balling, R. (2019). Connecting environmental exposure and neurodegeneration using cheminformatics and high resolution mass spectrometry: potential and challenges. Environmental Science. Processes and Impacts. doi:10.1039/C9EM00068B ![]() |
![]() ![]() | Krüger, R., EARLYSTIM study group, & Barbe, M. (2019). Deep Brain Stimulation for Freezing of Gait in Parkinson’s Disease With Early Motor Complications. Movement Disorders. doi:10.1002/mds.27892 ![]() |
![]() ![]() | Grossmann, D., Berenguer, C., Bellet, M. E., Scheibner, D., Bohler, J., Massart, F., Rapaport, D., Skupin, A., Fouquier d'Hérouël, A., Sharma, M., Ghelfi, J., Rakovic, A., Lichtner, P., Antony, P., Glaab, E., May, P., Dimmer, K. S., Fitzgerald, J. C., Grünewald, A., & Krüger, R. (2019). Mutations in RHOT1 disrupt ER-mitochondria contact sites interfering with calcium homeostasis and mitochondrial dynamics in Parkinson's disease. Antioxidants & redox signaling. doi:10.1089/ars.2018.7718 ![]() |
![]() ![]() | Arias, J., Jarazo, J., Walter, J., Gomez Giro, G., Forster, J., Antony, P., Krüger, R., & Schwamborn, J. C. (2019). Automated high-throughput high-content autophagy and mitophagy analysis platform. Scientific Reports. doi:10.1038/s41598-019-45917-2 ![]() |
![]() ![]() | Krüger, R., Riederer, P., Berg, D., Casadei, N., Cheng, F., Claßen, J., Dresel, C., & Jost, W. (2019). α-Synuclein in Parkinson's disease: causal or bystander? Journal of Neural Transmission. doi:10.1007/s00702-019-02025-9 ![]() |
![]() ![]() | Krüger, R., Vollstedt, E. J., Kasten, M., Klein, C., & MJFF Global Genetic Parkinson's Disease Study Group. (2019). Using global team science to identify genetic parkinson's disease worldwide. Annals of Neurology. doi:10.1002/ana.25514 ![]() |
Smits, L., Magni, S., Grzyb, K., Antony, P., Krüger, R., Skupin, A., Bolognin, S., & Schwamborn, J. C. (2019). Single-cell transcriptomics reveals multiple neuronal cell types in human midbrain-specific organoids. ORBilu-University of Luxembourg. https://orbilu.uni.lu/handle/10993/39342. doi:10.1101/589598 |
![]() ![]() | Krüger, R., Gerlach, M., Sharma, M., Romanos, M., Lech, K. P., Walitza, S., Conzelmann, A. H., & Renner, T. R. (2019). Family-based association study on functional α-synuclein polymorphisms in attention-deficit/hyperactivity disorder. ADHD Attention Deficit and Hyperactivity Disorders. doi:10.1007/s12402-019-00286-8 ![]() |
![]() ![]() | Krüger, R., EARLYSTIM study group, Schuepbach, M., & Deuschl, G. (2019). Quality of life predicts outcome of deep brain stimulation in early Parkinson disease. Neurology. doi:10.1212/WNL.0000000000007037 ![]() |
![]() ![]() | Hertel, J., Harms, A. C., Heinken, A., Baldini, F., Thinnes, C. C., Glaab, E., Vasco, D., Pietzner, M., Stewart, I. D., Wareham, N. J., Langenberg, C., Trenkwalder, C., Krüger, R., Hankemeier, T., Fleming, R. M. T., Mollenhauer, B., & Thiele, I. (2019). Integrated Analyses of Microbiome and Longitudinal Metabolome Data Reveal Microbial-Host Interactions on Sulfur Metabolism in Parkinson’s Disease. Cell Reports, 29 (7), 1767-1777. doi:10.1016/j.celrep.2019.10.035 ![]() |
![]() ![]() | Hanss, Z., Boussaad, I., Jarazo, J., Schwamborn, J. C., & Krüger, R. (2019). Quality Control Strategy for CRISPRCas9- based Gene Editing Complicated by a Pseudogene. Frontiers in Genetics. doi:10.3389/fgene.2019.01297 ![]() |
![]() ![]() | Schoellmann, A., Scholten, M., Wasserka, B., Govindan, R. B., Krüger, R., Gharabaghi, A., Plewnia, C., & Weiss, D. (2019). Anodal tDCS modulates cortical activity and synchronization in Parkinson's disease depending on motor processing. NeuroImage: Clinical, 22, 101689. doi:10.1016/j.nicl.2019.101689 ![]() |
![]() ![]() | Keller, A., Fehlmann, T., Laufer, T., Backes, C., Kahramann, M., Alles, J., Fischer, U., Minet, M., Ludwig, N., Kern, F., Kehl, T., Galata, V., Dusterloh, A., Schrors, H., Kohlhaas, J., Bals, R., Huwer, H., Geffers, L., Krüger, R., ... Meese, E. (2018). Large-scale validation of miRNAs by disease association, evolutionary conservation and pathway activity. RNA Biology. doi:10.1080/15476286.2018.1559689 ![]() |
![]() ![]() | Krüger, R., Klucken, J., Bloem, B., & Schimdt, P. (2018). Management of Parkinson’s Disease 20 Years from Now: Towards Digital Health Pathways. Journal of Parkinson's Disease. doi:10.3233/JPD-181519 ![]() |
![]() ![]() | Krüger, R., Kishore, A., Comprehensive Unbiased Risk Factor Assessment for Genetics and Environment in Parkinson's Disease (COURAGE-PD), & Sreelatha, A. A. K. (2018). Understanding the role of genetic variability in LRRK2 in Indian population. Movement Disorders. doi:10.1002/mds.27558 ![]() |
![]() ![]() | Hipp Epouse D'amico, G., Vaillant, M., Diederich, N. J., Roomp, K., Satagopam, V., Banda, P., Sandt, E., Mommaerts, K., Schmitz, S., Longhino, L., Schweicher, A., Hanff, A.-M., Nicolai, B., Kolber, P. L., Reiter, D., Pavelka, L., Binck, S., Pauly, C., Geffers, L., ... Krüger, R. (29 October 2018). The Luxembourg Parkinson’s Study: A Comprehensive Approach for Stratification and Early Diagnosis. Frontiers in Aging Neuroscience, 10, 326. doi:10.3389/fnagi.2018.00326 ![]() |
![]() ![]() | Krüger, R., Blauwendraat, C., & International Parkinson's Disease Genomics Consortium (IPDGC), COURAGE-PD Consortium. (2018). Insufficient Evidence for Pathogenicity of SNCA His50Gln (H50Q) in Parkinson's Disease. Neurobiology of Aging. doi:10.1016/j.neurobiolaging.2017.12.012 ![]() |
![]() ![]() | Fitzgerald, J. C., Zimprich, A., Bobbili, D. R., Sharma, M., May, P., & Krüger, R. (2018). Reply: No evidence for rare TRAP1 mutations influencing the risk of idiopathic Parkinson’s disease. Brain: a Journal of Neurology. doi:10.1093/brain/awx380 ![]() |
![]() ![]() | Krüger, R., Larsen, S., & Hanss, Z. (2018). The genetic architecture of mitochondrial dysfunction in Parkinson's Disease. Cell and Tissue Research. doi:10.1007/s00441-017-2768-8 ![]() |
![]() ![]() | Riederer, P., Jellinger, K. A., Kolber, P. L., Hipp, G., Sian-Hulsmann, J., & Krüger, R. (2018). Lateralisation in Parkinson disease. Cell and Tissue Research, 373 (1), 297-312. doi:10.1007/s00441-018-2832-z ![]() |
![]() ![]() | Lhommee, E., Wojtecki, L., Czernecki, V., Witt, K., Maier, F., Tonder, L., Timmermann, L., Halbig, T. D., Pineau, F., Durif, F., Witjas, T., Pinsker, M., Mehdorn, M., Sixel-Doring, F., Kupsch, A., Krüger, R., Elben, S., Chabardes, S., Thobois, S., ... Krack, P. (2018). Behavioural outcomes of subthalamic stimulation and medical therapy versus medical therapy alone for Parkinson's disease with early motor complications (EARLYSTIM trial): secondary analysis of an open-label randomised trial. The Lancet. Neurology, 17 (3), 223-231. doi:10.1016/S1474-4422(18)30035-8 ![]() |
![]() ![]() | Harmuth, T., Prell-Schicker, C., Weber, J. J., Gellerich, F., Funke, C., Driessen, S., Magg, J. C. D., Krebiehl, G., Wolburg, H., Hayer, S. N., Hauser, S., Krüger, R., Schols, L., Riess, O., & Hubener-Schmid, J. (2018). Mitochondrial Morphology, Function and Homeostasis Are Impaired by Expression of an N-terminal Calpain Cleavage Fragment of Ataxin-3. Frontiers in Molecular Neuroscience, 11, 368. doi:10.3389/fnmol.2018.00368 ![]() |
![]() ![]() | Hanci, I., Kamm, C., Scholten, M., Roncoroni, L. P., Weber, Y., Krüger, R., Plewnia, C., Gharabaghi, A., & Weiss, D. (2018). Long-Term Effect of GPi-DBS in a Patient With Generalized Dystonia Due to GLUT1 Deficiency Syndrome. Frontiers in Neurology, 9, 381. doi:10.3389/fneur.2018.00381 ![]() |
![]() ![]() | Burbulla, L. F., Song, P., Mazzulli, J. R., Zampese, E., Wong, Y. C., Jeon, S., Santos, D. P., Blanz, J., Obermaier, C. D., Strojny, C., Savas, J. N., Kiskinis, E., Zhuang, X., Krüger, R., Surmeier, D. J., & Krainc, D. (22 September 2017). Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson's disease. Science, 357 (6357), 1255-1261. doi:10.1126/science.aam9080 ![]() |
![]() ![]() | Fitzgerald, J. C., Zimprich, A., Carvajal-Berrio, D. A., Schindler, K. M., Maurer, B., Schulte, C., Bus, C., Hauser, A.-K., Kübler, M., Lewin, R., Bobbili, D. R., Schwarz, L. M., Vartholomaiou, E., Brockmann, K., Wüst, R., Madlung, J., Nordheim, A., Riess, O., Martins, L. M., ... Krüger, R. (24 August 2017). Metformin reverses TRAP1 mutation-associated alterations in mitochondrial function in Parkinson's disease. Brain: a Journal of Neurology, 140 (9), 2444-2459. doi:10.1093/brain/awx202 ![]() |
![]() ![]() | Krüger, R., Lingor, P., Doskas, T., Henselmans, J. M. L., Danielsen, E. H., de Fabregues, O., Stefani, A., Sensken, S.-C., Parra, J. C., Onuk, K., Yegin, A., & Antonini, A. (2017). An Observational Study of the Effect of Levodopa-Carbidopa Intestinal Gel on Activities of Daily Living and Quality of Life in Advanced Parkinson's Disease Patients. Advances in Therapy. doi:10.1007/s12325-017-0571-2 ![]() |
![]() ![]() | Bobbili, D. R., May, P., & Krüger, R. (02 June 2017). Rare variant analysis of the PPMI dataset to uncover the complex genetic architecture of Parkinson’s disease. Movement Disorders, 322 (Supplement S2), 405. doi:10.1002/mds.27087 ![]() |
![]() ![]() | Seidel, K., Bouzrou, M., Heidemann, N., Krüger, R., Schols, L., den Dunnen, W. F. A., Korf, H.-W., & Rub, U. (June 2017). Involvement of the cerebellum in Parkinson disease and dementia with Lewy bodies. Annals of Neurology, 81 (6), 898-903. doi:10.1002/ana.24937 ![]() |
![]() ![]() | Blauwendraat, C., Faghri, F., Pihlstrom, L., Geiger, J. T., Elbaz, A., Lesage, S., May, P., Aude, N., Abramzon, Y., Murphy, N. A., Gibbs, J. R., Ryten, M., Ferrari, R., Bras, J., Guerreiro, R., Williams, J., Sims, R., Lubbe, S., Hernandez, D. G., ... Scholz, S. W. (2017). NeuroChip, an updated version of the NeuroX genotyping platform to rapidly screen for variants associated with neurological diseases. Neurobiology of Aging. doi:10.1016/j.neurobiolaging.2017.05.009 ![]() |
![]() ![]() | Krüger, R., Klucken, J., Weiss, D., Tonges, L., Kolber, P. L., Unterecker, S., Lorrain, M., Baas, H., Muller, T., & Riederer, P. (24 March 2017). Classification of advanced stages of Parkinson's disease: translation into stratified treatments. Journal of Neural Transmission, 124 (124), 1015-1027. doi:10.1007/s00702-017-1707-x ![]() |
![]() ![]() | Straniero, L., Rimoldi, V., Samarani, M., Goldwurm, S., Di Fonzo, A., Krüger, R., Deleidi, M., Aureli, M., Solda, G., Duga, S., & Asselta, R. (2017). The GBAP1 pseudogene acts as a ceRNA for the glucocerebrosidase gene GBA by sponging miR-22-3p. Scientific Reports, 7 (1), 12702. doi:10.1038/s41598-017-12973-5 ![]() |
![]() ![]() | Scholten, M., Klemt, J., Heilbronn, M., Plewnia, C., Bloem, B. R., Bunjes, F., Krüger, R., Gharabaghi, A., & Weiss, D. (2017). Effects of Subthalamic and Nigral Stimulation on Gait Kinematics in Parkinson's Disease. Frontiers in Neurology, 8, 543. doi:10.3389/fneur.2017.00543 ![]() |
![]() ![]() | Wang, L., Heckman, M. G., Aasly, J. O., Annesi, G., Bozi, M., Chung, S. J., Clarke, C., Crosiers, D., Eckstein, G., Garraux, G., Hadjigeorgiou, G. M., Hattori, N., Jeon, B., Kim, Y. J., Kubo, M., Lesage, S., Lin, J. J., Lynch, T., Lichtner, P., ... Sharma, M. (January 2017). Evaluation of the interaction between LRRK2 and PARK16 loci in determining risk of Parkinson's disease: analysis of a large multicenter study. Neurobiology of Aging, 49, 217.e1-217.e4. doi:10.1016/j.neurobiolaging.2016.09.022 ![]() |
![]() ![]() | Klionsky, D., & Krüger, R. (2016). Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy, 12 (1), 1-222. doi:10.1080/15548627.2015.1100356 ![]() |
![]() ![]() | Casadei, N., Sood, P., Ulrich, T., Kieper, N., Helling, S., May, C., Glaab, E., Chen, J., Nuber, S., Marcus, K., Rapaport, D., Ott, T., Riess, O., Krüger, R., & Fitzgerald, J. (2016). Mitochondrial Defects and Neurodegeneration in Mice Overexpressing Wild Type or G399S Mutant HtrA2. Human Molecular Genetics, 25 (3), 459-71. doi:10.1093/hmg/ddv485 ![]() |
![]() ![]() | Scholten, M., Klotz, R., Plewnia, C., Wachter, T., Mielke, C., Bloem, B. R., Braun, C., Ziemann, U., Govindan, R. B., Gharabaghi, A., Krüger, R., & Weiss, D. (2016). Neuromuscular correlates of subthalamic stimulation and upper limb freezing in Parkinson's disease. Clinical Neurophysiology. doi:10.1016/j.clinph.2015.02.012 ![]() |
![]() ![]() | Scholten, M., Govindan, R. B., Braun, C., Bloem, B. R., Plewnia, C., Krüger, R., Gharabaghi, A., & Weiss, D. (2016). Cortical correlates of susceptibility to upper limb freezing in Parkinson's disease. Clinical Neurophysiology, 127 (6), 2386-93. doi:10.1016/j.clinph.2016.01.028 ![]() |
![]() ![]() | Heinzel, S., Roeben, B., Ben-Shlomo, Y., Lerche, S., Alves, G., Barone, P., Behnke, S., Berendse, H. W., Bloem, B. R., Burn, D., Dodel, R., Grosset, D. G., Hu, M., Kasten, M., Krüger, R., Moccia, M., Mollenhauer, B., Oertel, W., Suenkel, U., ... Berg, D. (2016). Prodromal Markers in Parkinson's Disease: Limitations in Longitudinal Studies and Lessons Learned. Frontiers in Aging Neuroscience, 8, 147. doi:10.3389/fnagi.2016.00147 ![]() |
![]() ![]() | Lerche, S., Heinzel, S., Alves, G. W., Barone, P., Behnke, S., Ben-Shlomo, Y., Berendse, H., Bloem, B. R., Burn, D., Dodel, R., Grosset, D. G., Hipp, G., Hu, M. T., Kasten, M., Krüger, R., Liepelt-Scarfone, I., Maetzler, W., Moccia, M., Mollenhauer, B., ... Berg, D. (2016). Aiming for Study Comparability in Parkinson's Disease: Proposal for a Modular Set of Biomarker Assessments to be Used in Longitudinal Studies. Frontiers in Aging Neuroscience, 8, 121. doi:10.3389/fnagi.2016.00121 ![]() |
![]() ![]() | Maetzler, W., Krüger, R., Muller, T., Oertel, W., Urban, P., Warnecke, T., & Klucken, J. (2016). Tragbare und aktiv vom Parkinson-Patienten genutzte Technologie im hauslichen Umfeld: Was bringt die Zukunft? Fortschritte der Neurologie-Psychiatrie, 84 Suppl 1, 48-51. doi:10.1055/s-0042-102786 ![]() |
![]() ![]() | Wüst, R., Maurer, B., Hauser, K., Woitalla, D., Sharma, M., & Krüger, R. (2016). Mutation analyses and association studies to assess the role of the presenilin-associated rhomboid-like gene in Parkinson's disease. Neurobiology of Aging, 39, 217.e13 - 217.e15. doi:10.1016/j.neurobiolaging.2015.11.025 ![]() |
![]() ![]() | Krüger, R., Hilker, R., Winkler, C., Lorrain, M., Hahne, M., Redecker, C., Lingor, P., & Jost, W. H. (2016). Advanced stages of PD: interventional therapies and related patient-centered care. Journal of Neural Transmission. doi:10.1007/s00702-015-1418-0 ![]() |
![]() ![]() | Meiser, J., Delcambre, S., Wegner, A., Jäger, C., Ghelfi, J., Fouquier d'Hérouël, A., Dong, X., Weindl, D., Stautner, C., Nonnenmacher, Y., Michelucci, A., Popp, O., Giesert, F., Schildknecht, S., Kraemer, L., Schneider, J. G., Woitalla, D., Wurst, W., Skupin, A., ... Hiller, K. (2016). Loss of DJ-1 impairs antioxidant response by altered glutamine and serine metabolism. Neurobiology of Disease, 89, 112-125. doi:10.1016/j.nbd.2016.01.019 ![]() |
![]() ![]() | Dams, J., Balzer-Geldsetzer, M., Siebert, U., Deuschl, G., Schuepbach, W. M., Krack, P., Timmermann, L., Schnitzler, A., Reese, J.-P., Dodel, R., Krüger, R., & EARLYSTIM-investigators. (2016). Cost-Effectiveness of Neurostimulation in Parkinson's Disease With Early Motor Complications. Movement Disorders, 31 (8), 1183-1191. doi:10.1002/mds.26740 ![]() |
![]() ![]() | Weiss, D., Herrmann, S., Wang, L., Schulte, C., Brockmann, K., Plewnia, C., Gasser, T., Sharma, M., Gharabaghi, A., & Krüger, R. (2016). Alpha-synuclein gene variants may predict neurostimulation outcome. Movement Disorders. doi:10.1002/mds.26558 ![]() |
![]() ![]() | Weiss, D., Klotz, R., Govindan, R. B., Scholten, M., Naros, G., Ramos-Murguialday, A., Bunjes, F., Meisner, C., Plewnia, C., Krüger, R., & Gharabaghi, A. (2015). Subthalamic stimulation modulates cortical motor network activity and synchronization in Parkinson's disease. Brain: a Journal of Neurology, 138 (Pt 3), 679-93. doi:10.1093/brain/awu380 ![]() |
![]() ![]() | Bruggemann, N., Kuhn, A., Schneider, S. A., Kamm, C., Wolters, A., Krause, P., Moro, E., Steigerwald, F., Wittstock, M., Tronnier, V., Lozano, A. M., Hamani, C., Poon, Y. Y., Zittel, S., Wachter, T., Deuschl, G., Krüger, R., Kupsch, A., Munchau, A., ... Klein, C. (2015). Short- and long-term outcome of chronic pallidal neurostimulation in monogenic isolated dystonia. Neurology, 84 (9), 895-903. doi:10.1212/WNL.0000000000001312 ![]() |
![]() ![]() | Chen, J., Shinde, S., Koch, M.-H., Eisenacher, M., Galozzi, S., Lerari, T., Barkovits, K., Subedi, P., Krüger, R., Kuhlmann, K., Sellergren, B., Helling, S., & Marcus, K. (2015). Low-bias phosphopeptide enrichment from scarce samples using plastic antibodies. Scientific Reports, 5, 11438. doi:10.1038/srep11438 ![]() |
![]() ![]() | Nieratschker, V., Kiefer, C., Giel, K., Krüger, R., & Plewnia, C. (2015). The COMT Val/Met polymorphism modulates effects of tDCS on response inhibition. Brain stimulation, 8 (2), 283-288. doi:10.1016/j.brs.2014.11.009 ![]() |
![]() ![]() | Maus, F., Sakry, D., Biname, F., Karram, K., Rajalingam, K., Watts, C., Heywood, R., Krüger, R., Stegmuller, J., Werner, H. B., Nave, K. A., Kramer-Albers, E. M., & Trotter, J. (2015). The NG2 Proteoglycan Protects Oligodendrocyte Precursor Cells against Oxidative Stress via Interaction with OMI/HtrA2. PLoS ONE, 10 (9), 0137311. doi:10.1371/journal.pone.0137311 ![]() |
![]() ![]() | Wang, L., Aasly, J. O., Annesi, G., Bardien, S., Bozi, M., Brice, A., Carr, J., Chung, S. J., Clarke, C., Crosiers, D., Deutschlander, A., Eckstein, G., Farrer, M. J., Goldwurm, S., Garraux, G., Hadjigeorgiou, G. M., Hicks, A. A., Hattori, N., Klein, C., ... Sharma, M. (2015). Large-scale assessment of polyglutamine repeat expansions in Parkinson disease. Neurology, 85 (15), 1283-92. doi:10.1212/WNL.0000000000002016 ![]() |
![]() ![]() | Lerche, S., Liepelt-Scarfone, I., Alves, G., Barone, P., Behnke, S., Ben-Shlomo, Y., Berendse, H., Burn, D., Dodel, R., Grosset, D., Heinzel, S., Hu, M., Kasten, M., Krüger, R., Maetzler, W., Moccia, M., Mollenhauer, B., Oertel, W., Roeben, B., ... Berg, D. (2015). Methods in Neuroepidemiology Characterization of European Longitudinal Cohort Studies in Parkinson's Disease - Report of the JPND Working Group BioLoC-PD. Neuroepidemiology, 45 (4), 282-297. doi:10.1159/000439221 ![]() |
![]() ![]() | Odin, P., Chaudhuri, K. R., Slevin, J. T., Volkmann, J., Dietrichs, E., Martinez-Martin, P., Krauss, J. K., Henriksen, T., Katzenschlager, R., Antonini, A., Rascol, O., Poewe, W., Krüger, R., & National Steering Committees. (2015). Collective physician perspectives on non-oral medication approaches for the management of clinically relevant unresolved issues in Parkinson's disease: Consensus from an international survey and discussion program. Parkinsonism and Related Disorders. doi:10.1016/j.parkreldis.2015.07.020 ![]() |
![]() ![]() | Puschmann, A., Brighina, L., Markopoulou, K., Aasly, J., Chung, S. J., Frigerio, R., Hadjigeorgiou, G., Koks, S., Krüger, R., Siuda, J., Wider, C., Zesiewicz, T. A., & Maraganore, D. M. (2015). Clinically meaningful parameters of progression and long-term outcome of Parkinson disease: An international consensus statement. Parkinsonism and Related Disorders, 21 (7), 675-682. doi:10.1016/j.parkreldis.2015.04.029 ![]() |
![]() ![]() | Lew, M. F., Slevin, J. T., Krüger, R., Martinez, C., Chatamra, K., Dubow, J. S., Robieson, W. Z., Benesh, J. A., & Fung, V. S. (2015). Initiation and dose optimization for levodopa-carbidopa intestinal gel: Insights from phase 3 clinical trials. Parkinsonism and Related Disorders, 21 (7), 742-748. doi:10.1016/j.parkreldis.2015.04.022 ![]() |
![]() ![]() | Ortega-Cubero, S., Lorenzo-Betancor, O., Lorenzo, E., Agundez, J. A., Jimenez-Jimenez, F. J., Ross, O. A., Wurster, I., Mielke, C., Lin, J. J., Coria, F., Clarimon, J., Ezquerra, M., Brighina, L., Annesi, G., Alonso-Navarro, H., Garcia-Martin, E., Gironell, A., Marti, M. J., Yueh, K. C., ... Pastor, P. (2015). TREM2 R47H variant and risk of essential tremor: a cross-sectional international multicenter study. Parkinsonism and Related Disorders, 21 (3), 306-309. doi:10.1016/j.parkreldis.2014.12.010 ![]() |
![]() ![]() | Weiss, D., Mielke, C., Wachter, T., Bender, B., Liscic, R. M., Scholten, M., Naros, G., Plewnia, C., Gharabaghi, A., & Krüger, R. (2015). Long-term outcome of deep brain stimulation in fragile X-associated tremor/ataxia syndrome. Parkinsonism and Related Disorders, 21 (3), 310-313. doi:10.1016/j.parkreldis.2014.12.015 ![]() |
![]() ![]() | Jonmohamadi, Y., Poudel, Innes, C., Weiss, D., Krüger, R., & Jones, R. (November 2014). Comparison of beamformers for EEG source signal reconstruction. Biomedical Signal Processing and Control, 14, 175-188. doi:10.1016/j.bspc.2014.07.014 ![]() |
![]() ![]() | Weiss, D., Lam, J. M., Breit, S., Gharabaghi, A., Krüger, R., Luft, A. R., & Wachter, T. (2014). The subthalamic nucleus modulates the early phase of probabilistic classification learning. Experimental Brain Research, 232 (7), 2255-62. doi:10.1007/s00221-014-3916-y ![]() |
![]() ![]() | Sharma, M., Wenning, G., & Krüger, R. (2014). Mutant COQ2 in multiple-system atrophy. The New England journal of medicine, 371 (1), 80-1. doi:10.1056/NEJMc1311763 ![]() |
![]() ![]() | Casadei, N., Pohler, A.-M., Tomas-Zapico, C., Torres-Peraza, J., Schwedhelm, I., Witz, A., Zamolo, I., De Heer, R., Spruijt, B., Noldus, L. P. J. J., Klucken, J., Lucas, J. J., Kahle, P. J., Krüger, R., Riess, O., & Nuber, S. (2014). Overexpression of synphilin-1 promotes clearance of soluble and misfolded alpha-synuclein without restoring the motor phenotype in aged A30P transgenic mice. Human Molecular Genetics, 23 (3), 767-81. doi:10.1093/hmg/ddt467 ![]() |
![]() ![]() | Theuns, J., Verstraeten, A., Sleegers, K., Wauters, E., Gijselinck, I., Smolders, S., Crosiers, D., Corsmit, E., Elinck, E., Sharma, M., Krüger, R., Lesage, S., Brice, A., Chung, S. J., Kim, M.-J., Kim, Y. J., Ross, O. A., Wszolek, Z. K., Rogaeva, E., ... Van Broeckhoven, C. (2014). Global investigation and meta-analysis of the C9orf72 (G4C2)n repeat in Parkinson disease. Neurology. doi:10.1212/WNL.0000000000001012 ![]() |
![]() ![]() | Sharma, M., Krüger, R., & Gasser, T. (2014). From genome-wide association studies to next-generation sequencing: lessons from the past and planning for the future. JAMA Neurology, 71 (1), 5-6. doi:10.1001/jamaneurol.2013.3682 ![]() |
![]() ![]() | Huttenlocher, J., Krüger, R., Capetian, P., Lohmann, K., Brockmann, K., Csoti, I., Klein, C., Berg, D., Gasser, T., Bonin, M., Riess, O., & Bauer, P. (2014). EIF4G1 is neither a strong nor a common risk factor for Parkinson's disease: evidence from large European cohorts. Journal of Medical Genetics, 0, 1-5. doi:10.1136/jmedgenet-2014-102570 ![]() |
![]() ![]() | Burbulla, L. F., Fitzgerald, J. C., Stegen, K., Westermeier, J., Thost, A.-K., Kato, H., Mokranjac, D., Sauerwald, J., Martins, L., Woitalla, D., Rapaport, D., Riess, O., Proikas-Cezanne, T., Rasse, T. M., & Krüger, R. (2014). Mitochondrial proteolytic stress induced by loss of mortalin function is rescued by Parkin and PINK1. Cell Death and Disease, 5, 1180. doi:10.1038/cddis.2014.103 ![]() |
![]() ![]() | Heckman, M. G., Elbaz, A., Soto-Ortolaza, A. I., Serie, D. J., Aasly, J. O., Annesi, G., Auburger, G., Bacon, J. A., Boczarska-Jedynak, M., Bozi, M., Brighina, L., Chartier-Harlin, M.-C., Dardiotis, E., Destee, A., Ferrarese, C., Ferraris, A., Fiske, B., Gispert, S., Hadjigeorgiou, G. M., ... Ross, O. A. (2014). Protective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variants. Neurobiology of Aging, 35 (1), 266.e5-14. doi:10.1016/j.neurobiolaging.2013.07.013 ![]() |
![]() ![]() | Chung, S. J., Biernacka, J. M., Armasu, S. M., Anderson, K., Frigerio, R., Aasly, J. O., Annesi, G., Bentivoglio, A. R., Brighina, L., Chartier-Harlin, M.-C., Goldwurm, S., Hadjigeorgiou, G., Jasinska-Myga, B., Jeon, B. S., Kim, Y. J., Krüger, R., Lesage, S., Markopoulou, K., Mellick, G., ... Maraganore, D. M. (2014). Alpha-synuclein repeat variants and survival in Parkinson's disease. Movement Disorders. doi:10.1002/mds.25841 ![]() |
![]() ![]() | Antony, P., Diederich, N., Krüger, R., & Balling, R. (2013). The hallmarks of Parkinson's disease. FEBS Journal, 13. doi:10.1111/febs.12335 ![]() |
![]() ![]() | Zhu, J.-Y., Vereshchagina, N., Sreekumar, V., Burbulla, L. F., Costa, A. C., Daub, K. J., Woitalla, D., Martins, L., Krüger, R., & Rasse, T. M. (2013). Knockdown of Hsc70-5/mortalin induces loss of synaptic mitochondria in a Drosophila Parkinson's disease model. PLoS ONE, 8 (12), 83714. doi:10.1371/journal.pone.0083714 ![]() |
![]() ![]() | Weiss, D., Walach, M., Meisner, C., Fritz, M., Scholten, M., Breit, S., Plewnia, C., Bender, B., Gharabaghi, A., Wachter, T., & Krüger, R. (2013). Nigral stimulation for resistant axial motor impairment in Parkinson's disease? A randomized controlled trial. Brain: a Journal of Neurology, 136 (Pt 7), 2098-108. doi:10.1093/brain/awt122 ![]() |
![]() ![]() | Schuepbach, W. M. M., Rau, J., Knudsen, K., Volkmann, J., Krack, P., Timmermann, L., Halbig, T. D., Hesekamp, H., Navarro, S. M., Meier, N., Falk, D., Mehdorn, M., Paschen, S., Maarouf, M., Barbe, M. T., Fink, G. R., Kupsch, A., Gruber, D., Schneider, G.-H., ... Deuschl, G. (2013). Neurostimulation for Parkinson's disease with early motor complications. The New England journal of medicine, 368 (7), 610-22. doi:10.1056/NEJMoa1205158 ![]() |
![]() ![]() | Grau, T., Burbulla, L. F., Engl, G., Delettre, C., Delprat, B., Oexle, K., Leo-Kottler, B., Roscioli, T., Krüger, R., Rapaport, D., Wissinger, B., & Schimpf-Linzenbold, S. (2013). A novel heterozygous OPA3 mutation located in the mitochondrial target sequence results in altered steady-state levels and fragmented mitochondrial network. Journal of Medical Genetics, 50 (12), 848-58. doi:10.1136/jmedgenet-2013-101774 ![]() |
![]() ![]() | Riess, A., Rossier, E., Krüger, R., Dufke, A., Beck-Woedl, S., Horber, V., Alber, M., Glaser, D., Riess, O., & Tzschach, A. (2013). Novel SLC9A6 mutations in two families with Christianson syndrome. Clinical Genetics, 83 (6), 596-7. doi:10.1111/j.1399-0004.2012.01948.x ![]() |
![]() ![]() | Karle, K. N., Biskup, S., Schule, R., Schweitzer, K. J., Krüger, R., Bauer, P., Bender, B., Nagele, T., & Schols, L. (2013). De novo mutations in hereditary diffuse leukoencephalopathy with axonal spheroids (HDLS). Neurology, 81 (23), 2039-44. doi:10.1212/01.wnl.0000436945.01023.ac ![]() |
![]() ![]() | Reinhardt, P., Schmid, B., Burbulla, L. F., Schondorf, D. C., Wagner, L., Glatza, M., Hoing, S., Hargus, G., Heck, S. A., Dhingra, A., Wu, G., Muller, S., Brockmann, K., Kluba, T., Maisel, M., Krüger, R., Berg, D., Tsytsyura, Y., Thiel, C. S., ... Sterneckert, J. (2013). Genetic correction of a LRRK2 mutation in human iPSCs links parkinsonian neurodegeneration to ERK-dependent changes in gene expression. Cell Stem Cell, 12 (3), 354-67. doi:10.1016/j.stem.2013.01.008 ![]() |
![]() ![]() | Plewnia, C., Zwissler, B., Langst, I., Maurer, B., Giel, K., & Krüger, R. (2013). Effects of transcranial direct current stimulation (tDCS) on executive functions: influence of COMT Val/Met polymorphism. Cortex: A Journal Devoted to the Study of the Nervous System and Behavior, 49 (7), 1801-7. doi:10.1016/j.cortex.2012.11.002 ![]() |
![]() ![]() | Heckman, M. G., Soto-Ortolaza, A. I., Aasly, J. O., Abahuni, N., Annesi, G., Bacon, J. A., Bardien, S., Bozi, M., Brice, A., Brighina, L., Carr, J., Chartier-Harlin, M.-C., Dardiotis, E., Dickson, D. W., Diehl, N. N., Elbaz, A., Ferrarese, C., Fiske, B., Gibson, J. M., ... Ross, O. A. (2013). Population-specific frequencies for LRRK2 susceptibility variants in the Genetic Epidemiology of Parkinson's Disease (GEO-PD) Consortium. Movement Disorders, 28 (12), 1740-4. doi:10.1002/mds.25600 ![]() |
![]() ![]() | Sharma, M., Ioannidis, J. P. A., Aasly, J. O., Annesi, G., Brice, A., Van Broeckhoven, C., Bertram, L., Bozi, M., Crosiers, D., Clarke, C., Facheris, M., Farrer, M., Garraux, G., Gispert, S., Auburger, G., Vilarino-Guell, C., Hadjigeorgiou, G. M., Hicks, A. A., Hattori, N., ... Krüger, R. (2012). Large-scale replication and heterogeneity in Parkinson disease genetic loci. Neurology, 79 (7), 659-67. doi:10.1212/WNL.0b013e318264e353 ![]() |
![]() ![]() | Weiss, D., Breit, S., Hoppe, J., Hauser, A.-K., Freudenstein, D., Krüger, R., Sauseng, P., Govindan, R. B., & Gerloff, C. (2012). Subthalamic nucleus stimulation restores the efferent cortical drive to muscle in parallel to functional motor improvement. The European journal of neuroscience, 35 (6), 896-908. doi:10.1111/j.1460-9568.2012.08014.x ![]() |
![]() ![]() | Sharma, M., Ioannidis, J. P. A., Aasly, J. O., Annesi, G., Brice, A., Bertram, L., Bozi, M., Barcikowska, M., Crosiers, D., Clarke, C. E., Facheris, M. F., Farrer, M., Garraux, G., Gispert, S., Auburger, G., Vilarino-Guell, C., Hadjigeorgiou, G. M., Hicks, A. A., Hattori, N., ... Krüger, R. (2012). A multi-centre clinico-genetic analysis of the VPS35 gene in Parkinson disease indicates reduced penetrance for disease-associated variants. Journal of Medical Genetics, 49 (11), 721-6. doi:10.1136/jmedgenet-2012-101155 ![]() |
![]() ![]() | Fitzgerald, J. C., Camprubi, M. D., Dunn, L., Wu, H.-C., Ip, N. Y., Krüger, R., Martins, L., Wood, N. W., & Plun-Favreau, H. (2012). Phosphorylation of HtrA2 by cyclin-dependent kinase-5 is important for mitochondrial function. Cell Death and Differentiation, 19 (2), 257-66. doi:10.1038/cdd.2011.90 ![]() |
![]() ![]() | Weiss, D., Brockmann, K., Srulijes, K., Meisner, C., Klotz, R., Reinbold, S., Hauser, A.-K., Schulte, C., Berg, D., Gasser, T., Plewnia, C., Gharabaghi, A., Breit, S., Wachter, T., & Krüger, R. (2012). Long-term follow-up of subthalamic nucleus stimulation in glucocerebrosidase-associated Parkinson's disease. Journal of Neurology, 259 (9), 1970-2. doi:10.1007/s00415-012-6469-7 ![]() |
![]() ![]() | Klionsky, D. J., Abdalla, F. C., Abeliovich, H., Abraham, R. T., Acevedo-Arozena, A., Adeli, K., Agholme, L., Agnello, M., Agostinis, P., Aguirre-Ghiso, J. A., Ahn, H. J., Ait-Mohamed, O., Ait-Si-Ali, S., Akematsu, T., Akira, S., Al-Younes, H. M., Al-Zeer, M. A., Albert, M. L., Albin, R. L., ... Zuckerbraun, B. (2012). Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy, 8 (4), 445-544. doi:10.4161/auto.19496 ![]() |
![]() ![]() | Burbulla, L. F., & Krüger, R. (2012). The use of primary human fibroblasts for monitoring mitochondrial phenotypes in the field of Parkinson's disease. Journal of Visualized Experiments, (68). doi:10.3791/4228 ![]() |
![]() ![]() | Sharma, M., Krüger, R., & Gasser, T. (2012). LRRK2: Understanding the role of common and rare variants in Parkinson's disease. Movement Disorders, 27 (4), 475. doi:10.1002/mds.24937 ![]() |
![]() ![]() | Gispert, S., Kurz, A., Waibel, S., Bauer, P., Liepelt, I., Geisen, C., Gitler, A. D., Becker, T., Weber, M., Berg, D., Andersen, P. M., Krüger, R., Riess, O., Ludolph, A. C., & Auburger, G. (2012). The modulation of Amyotrophic Lateral Sclerosis risk by ataxin-2 intermediate polyglutamine expansions is a specific effect. Neurobiology of Disease, 45 (1), 356-61. doi:10.1016/j.nbd.2011.08.021 ![]() |
![]() ![]() | Lengerer, S., Kipping, J., Rommel, N., Weiss, D., Breit, S., Gasser, T., Plewnia, C., Krüger, R., & Wachter, T. (2012). Deep-brain-stimulation does not impair deglutition in Parkinson's disease. Parkinsonism and Related Disorders, 18 (7), 847-53. doi:10.1016/j.parkreldis.2012.04.014 ![]() |
![]() ![]() | Weiss, D., Wachter, T., Meisner, C., Fritz, M., Gharabaghi, A., Plewnia, C., Breit, S., & Krüger, R. (2011). Combined STN/SNr-DBS for the treatment of refractory gait disturbances in Parkinson's disease: study protocol for a randomized controlled trial. Trials, 12, 222. doi:10.1186/1745-6215-12-222 ![]() |
![]() ![]() | Bruck, C., Wildgruber, D., Kreifelts, B., Krüger, R., & Wachter, T. (2011). Effects of subthalamic nucleus stimulation on emotional prosody comprehension in Parkinson's disease. PLoS ONE, 6 (4), 19140. doi:10.1371/journal.pone.0019140 ![]() |
![]() ![]() | Burbulla, L. F., & Krüger, R. (2011). Converging environmental and genetic pathways in the pathogenesis of Parkinson's disease. Journal of the Neurological Sciences, 306 (1-2), 1-8. doi:10.1016/j.jns.2011.04.005 ![]() |
![]() ![]() | Elbaz, A., Ross, O. A., Ioannidis, J. P. A., Soto-Ortolaza, A. I., Moisan, F., Aasly, J., Annesi, G., Bozi, M., Brighina, L., Chartier-Harlin, M.-C., Destee, A., Ferrarese, C., Ferraris, A., Gibson, J. M., Gispert, S., Hadjigeorgiou, G. M., Jasinska-Myga, B., Klein, C., Krüger, R., ... Farrer, M. J. (2011). Independent and joint effects of the MAPT and SNCA genes in Parkinson disease. Annals of Neurology, 69 (5), 778-92. doi:10.1002/ana.22321 ![]() |
![]() ![]() | Weiss, D., Breit, S., Wachter, T., Plewnia, C., Gharabaghi, A., & Krüger, R. (2011). Combined stimulation of the substantia nigra pars reticulata and the subthalamic nucleus is effective in hypokinetic gait disturbance in Parkinson's disease. Journal of Neurology, 258 (6), 1183-5. doi:10.1007/s00415-011-5906-3 ![]() |
![]() ![]() | Weiss, D., Brockmann, K., Nagele, T., Gasser, T., & Krüger, R. (2011). Rapid emergence of temporal and pulvinar lesions in MELAS mimicking Creutzfeldt-Jakob disease. Neurology, 77 (9), 914. doi:10.1212/WNL.0b013e31822c6275 ![]() |
![]() ![]() | Wachter, T., Engeholm, M., Bisdas, S., Schittenhelm, J., Gasser, T., & Krüger, R. (2011). Slowly progressive Parkinson syndrome due to thalamic butterfly astrocytoma. Neurology, 77 (4), 404-5. doi:10.1212/WNL.0b013e3182267bc4 ![]() |
![]() ![]() | Rzesnitzek, L., Wachter, T., Krüger, R., Gharabaghi, A., & Plewnia, C. (2011). Suppression of extrapyramidal side effects of doxepin by thalamic deep brain stimulation for Tourette syndrome. Neurology, 77 (18), 1708-9. doi:10.1212/WNL.0b013e318236485f ![]() |
![]() ![]() | Ross, O. A., Soto-Ortolaza, A. I., Heckman, M. G., Aasly, J. O., Abahuni, N., Annesi, G., Bacon, J. A., Bardien, S., Bozi, M., Brice, A., Brighina, L., Van Broeckhoven, C., Carr, J., Chartier-Harlin, M.-C., Dardiotis, E., Dickson, D. W., Diehl, N. N., Elbaz, A., Ferrarese, C., ... Farrer, M. J. (2011). Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case-control study. Lancet Neurology, 10 (10), 898-908. doi:10.1016/S1474-4422(11)70175-2 ![]() |
![]() ![]() | Weiss, D., Govindan, R. B., Rilk, A., Wachter, T., Breit, S., Zizlsperger, L., Haarmeier, T., Plewnia, C., Krüger, R., & Gharabaghi, A. (2011). Central oscillators in a patient with neuropathic tremor: evidence from intraoperative local field potential recordings. Movement Disorders, 26 (2), 323-7. doi:10.1002/mds.23374 ![]() |
![]() ![]() | Nuber, S., Petrasch-Parwez, E., Arias-Carrion, O., Koch, L., Kohl, Z., Schneider, J., Calaminus, C., Dermietzel, R., Samarina, A., Boy, J., Nguyen, H. P., Teismann, P., Velavan, T. P., Kahle, P. J., von Horsten, S., Fendt, M., Krüger, R., & Riess, O. (2011). Olfactory neuron-specific expression of A30P alpha-synuclein exacerbates dopamine deficiency and hyperactivity in a novel conditional model of early Parkinson's disease stages. Neurobiology of Disease, 44 (2), 192-204. doi:10.1016/j.nbd.2011.06.017 ![]() |
![]() ![]() | Krüger, R., Sharma, M., Riess, O., Gasser, T., Van Broeckhoven, C., Theuns, J., Aasly, J., Annesi, G., Bentivoglio, A. R., Brice, A., Djarmati, A., Elbaz, A., Farrer, M., Ferrarese, C., Gibson, J. M., Hadjigeorgiou, G. M., Hattori, N., Ioannidis, J. P. A., Jasinska-Myga, B., ... Maraganore, D. M. (2011). A large-scale genetic association study to evaluate the contribution of Omi/HtrA2 (PARK13) to Parkinson's disease. Neurobiology of Aging, 32 (3), 548.e9-18. doi:10.1016/j.neurobiolaging.2009.11.021 ![]() |
![]() ![]() | Sharma, M., Maraganore, D. M., Ioannidis, J. P. A., Riess, O., Aasly, J. O., Annesi, G., Abahuni, N., Bentivoglio, A. R., Brice, A., Van Broeckhoven, C., Chartier-Harlin, M.-C., Destee, A., Djarmati, A., Elbaz, A., Farrer, M., Ferrarese, C., Gibson, J. M., Gispert, S., Hattori, N., ... Krüger, R. (2011). Role of sepiapterin reductase gene at the PARK3 locus in Parkinson's disease. Neurobiology of Aging, 32 (11), 2108.e1-5. doi:10.1016/j.neurobiolaging.2011.05.024 ![]() |
![]() ![]() | Krebiehl, G., Ruckerbauer, S., Burbulla, L. F., Kieper, N., Maurer, B., Waak, J., Wolburg, H., Gizatullina, Z., Gellerich, F. N., Woitalla, D., Riess, O., Kahle, P. J., Proikas-Cezanne, T., & Krüger, R. (2010). Reduced basal autophagy and impaired mitochondrial dynamics due to loss of Parkinson's disease-associated protein DJ-1. PLoS ONE, 5 (2), 9367. doi:10.1371/journal.pone.0009367 ![]() |
![]() ![]() | Burbulla, L. F., Krebiehl, G., & Krüger, R. (2010). Balance is the challenge--the impact of mitochondrial dynamics in Parkinson's disease. European Journal of Clinical Investigation, 40 (11), 1048-60. doi:10.1111/j.1365-2362.2010.02354.x ![]() |
![]() ![]() | Burbulla, L. F., Schelling, C., Kato, H., Rapaport, D., Woitalla, D., Schiesling, C., Schulte, C., Sharma, M., Illig, T., Bauer, P., Jung, S., Nordheim, A., Schols, L., Riess, O., & Krüger, R. (2010). Dissecting the role of the mitochondrial chaperone mortalin in Parkinson's disease: functional impact of disease-related variants on mitochondrial homeostasis. Human Molecular Genetics, 19 (22), 4437-52. doi:10.1093/hmg/ddq370 ![]() |
![]() ![]() | Seidel, K., Schols, L., Nuber, S., Petrasch-Parwez, E., Gierga, K., Wszolek, Z., Dickson, D., Gai, W. P., Bornemann, A., Riess, O., Rami, A., Den Dunnen, W. F. A., Deller, T., Rub, U., & Krüger, R. (2010). First appraisal of brain pathology owing to A30P mutant alpha-synuclein. Annals of Neurology, 67 (5), 684-9. doi:10.1002/ana.21966 ![]() |
![]() ![]() | Nuber, S., Franck, T., Wolburg, H., Schumann, U., Casadei, N., Fischer, K., Calaminus, C., Pichler, B. J., Chanarat, S., Teismann, P., Schulz, J. B., Luft, A. R., Tomiuk, J., Wilbertz, J., Bornemann, A., Krüger, R., & Riess, O. (2010). Transgenic overexpression of the alpha-synuclein interacting protein synphilin-1 leads to behavioral and neuropathological alterations in mice. Neurogenetics, 11 (1), 107-20. doi:10.1007/s10048-009-0212-2 ![]() |
![]() ![]() | Soehn, A. S., Franck, T., Biskup, S., Giaime, E., Melle, C., Rott, R., Cebo, D., Kalbacher, H., Ott, E., Pahnke, J., Meitinger, T., Krüger, R., Gasser, T., Berg, D., von Eggeling, F., Engelender, S., da Costa, C. A., & Riess, O. (2010). Periphilin is a novel interactor of synphilin-1, a protein implicated in Parkinson's disease. Neurogenetics, 11 (2), 203-15. doi:10.1007/s10048-009-0215-z ![]() |
![]() ![]() | Weiss, D., Wachter, T., Breit, S., Jacob, S. N., Pomper, J. K., Asmus, F., Valls-Sole, J., Plewnia, C., Gasser, T., Gharabaghi, A., & Krüger, R. (2010). Involuntary eyelid closure after STN-DBS: evidence for different pathophysiological entities. Journal of Neurology, Neurosurgery and Psychiatry, 81 (9), 1002-7. doi:10.1136/jnnp.2009.196691 ![]() |
![]() ![]() | Breit, S., Wachter, T., Schmid-Bielenberg, D., Weiss, D., Leitner, P., Nagele, T., Freudenstein, D., Gasser, T., & Krüger, R. (2010). Effective long-term subthalamic stimulation in PARK8 positive Parkinson's disease. Journal of Neurology, 257 (7), 1205-7. doi:10.1007/s00415-010-5493-8 ![]() |
![]() ![]() | Synofzik, M., Weiss, D., Erharhaghen, J., Krüger, R., & Schols, L. (2010). Severe orthostatic dysregulation associated with Wolfram syndrome. Journal of Neurology, 257 (10), 1751-3. doi:10.1007/s00415-010-5593-5 ![]() |
![]() ![]() | Kieper, N., Holmstrom, K. M., Ciceri, D., Fiesel, F. C., Wolburg, H., Ziviani, E., Whitworth, A. J., Martins, L., Kahle, P. J., & Krüger, R. (2010). Modulation of mitochondrial function and morphology by interaction of Omi/HtrA2 with the mitochondrial fusion factor OPA1. Experimental Cell Research, 316 (7), 1213-24. doi:10.1016/j.yexcr.2010.01.005 ![]() |
![]() ![]() | Synofzik, M., Schule, R., Schulte, C., Krüger, R., Lindig, T., Schols, L., & Asmus, F. (2010). Complex hyperkinetic movement disorders associated with POLG mutations. Movement Disorders, 25 (14), 2472-5. doi:10.1002/mds.23307 ![]() |
![]() ![]() | Breit, S., Wachter, T., Schols, L., Gasser, T., Nagele, T., Freudenstein, D., & Krüger, R. (2009). Effective thalamic deep brain stimulation for neuropathic tremor in a patient with severe demyelinating neuropathy. Journal of Neurology, Neurosurgery and Psychiatry, 80 (2), 235-6. doi:10.1136/jnnp.2008.145656 ![]() |
![]() ![]() | Elstner, M., Morris, C. M., Heim, K., Lichtner, P., Bender, A., Mehta, D., Schulte, C., Sharma, M., Hudson, G., Goldwurm, S., Giovanetti, A., Zeviani, M., Burn, D. J., McKeith, I. G., Perry, R. H., Jaros, E., Krüger, R., Wichmann, H.-E., Schreiber, S., ... Turnbull, D. M. (2009). Single-cell expression profiling of dopaminergic neurons combined with association analysis identifies pyridoxal kinase as Parkinson's disease gene. Annals of Neurology, 66 (6), 792-8. doi:10.1002/ana.21780 ![]() |
![]() ![]() | Simon-Sanchez, J., Schulte, C., Bras, J. M., Sharma, M., Gibbs, J. R., Berg, D., Paisan-Ruiz, C., Lichtner, P., Scholz, S. W., Hernandez, D. G., Krüger, R., Federoff, M., Klein, C., Goate, A., Perlmutter, J., Bonin, M., Nalls, M. A., Illig, T., Gieger, C., ... Gasser, T. (2009). Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nature Genetics, 41 (12), 1308-12. doi:10.1038/ng.487 ![]() |
![]() ![]() | Wachter, T., Weiss, D., Breit, S., Gasser, T., Krüger, R., & Gharabaghi, A. (2009). Severe muscular fasciculations as an uncommon side-effect due to microdefect of an extension wire in deep brain stimulation. Movement Disorders, 24 (14), 2161-2. doi:10.1002/mds.22725 ![]() |
![]() ![]() | Sharma, M., Lichtner, P., Krüger, R., Berg, D., Schulte, C., Illig, T., Riess, O., & Gasser, T. (2009). Further delineation of the association signal on chromosome 5 from the first whole genome association study in Parkinson's disease. Neurobiology of Aging, 30 (10), 1706-9. doi:10.1016/j.neurobiolaging.2007.12.016 ![]() |
Schiesling, C., Kieper, N., Seidel, K., & Krüger, R. (2008). Review: Familial Parkinson's disease--genetics, clinical phenotype and neuropathology in relation to the common sporadic form of the disease. Neuropathology and Applied Neurobiology, 34 (3), 255-71. doi:10.1111/j.1365-2990.2008.00952.x ![]() |
Radke, S., Chander, H., Schafer, P., Meiss, G., Krüger, R., Schulz, J. B., & Germain, D. (2008). Mitochondrial protein quality control by the proteasome involves ubiquitination and the protease Omi. The Journal of biological chemistry, 283 (19), 12681-5. doi:10.1074/jbc.C800036200 ![]() |
Krüger, R. (2008). LRRK2 in Parkinson's disease - drawing the curtain of penetrance: a commentary. BMC Medicine, 6, 33. doi:10.1186/1741-7015-6-33 ![]() |
Plewnia, C., Schober, F., Rilk, A., Buchkremer, G., Reimold, M., Wachter, T., Breit, S., Weiss, D., Krüger, R., & Freudenstein, D. (2008). Sustained improvement of obsessive-compulsive disorder by deep brain stimulation in a woman with residual schizophrenia. The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP), 11 (8), 1181-3. doi:10.1017/S1461145708009188 ![]() |
Kamm, C., Fogel, W., Wachter, T., Schweitzer, K., Berg, D., Krüger, R., Freudenstein, D., & Gasser, T. (2008). Novel ATP1A3 mutation in a sporadic RDP patient with minimal benefit from deep brain stimulation. Neurology, 70 (16 Pt 2), 1501-3. doi:10.1212/01.wnl.0000310431.41036.e0 ![]() |
Tabatabai, G., Schober, W., Ernemann, U., Weller, M., & Krüger, R. (2008). Vertebral artery dissection presenting with ispilateral acute C5 and C6 sensorimotor radiculopathy: A case report. Cases Journal, 1 (1), 139. doi:10.1186/1757-1626-1-139 ![]() |
Bonin, M., Marx, F. P., Kautzmann, S., Riess, O., & Krüger, R. (2008). Microarray expression analysis reveals genetic pathways implicated in C621 synphilin-1-mediated toxicity. Journal of Neural Transmission, 115 (7), 941-58. doi:10.1007/s00702-008-0031-x ![]() |
Wahl, C., Kautzmann, S., Krebiehl, G., Strauss, K., Woitalla, D., Muller, T., Bauer, P., Riess, O., & Krüger, R. (2008). A comprehensive genetic study of the proteasomal subunit S6 ATPase in German Parkinson's disease patients. Journal of Neural Transmission, 115 (8), 1141-8. doi:10.1007/s00702-008-0054-3 ![]() |
Matzler, W., Nagele, T., Gasser, T., & Krüger, R. (2007). Acute parkinsonism with corresponding lesions in the basal ganglia after heroin abuse. Neurology, 68 (6), 414. doi:10.1212/01.wnl.0000250230.86581.ea ![]() |
Exner, N., Treske, B., Paquet, D., Holmstrom, K., Schiesling, C., Gispert, S., Carballo-Carbajal, I., Berg, D., Hoepken, H.-H., Gasser, T., Krüger, R., Winklhofer, K. F., Vogel, F., Reichert, A. S., Auburger, G., Kahle, P. J., Schmid, B., & Haass, C. (2007). Loss-of-function of human PINK1 results in mitochondrial pathology and can be rescued by parkin. The Journal of neuroscience : the official journal of the Society for Neuroscience, 27 (45), 12413-8. doi:10.1523/JNEUROSCI.0719-07.2007 ![]() |
Schweitzer, K. J., Brussel, T., Leitner, P., Krüger, R., Bauer, P., Woitalla, D., Tomiuk, J., Gasser, T., & Berg, D. (2007). Transcranial ultrasound in different monogenetic subtypes of Parkinson's disease. Journal of Neurology, 254 (5), 613-6. doi:10.1007/s00415-006-0369-7 ![]() |
![]() ![]() | Abahuni, N., Gispert, S., Bauer, P., Riess, O., Krüger, R., Becker, T., & Auburger, G. (2007). Mitochondrial translation initiation factor 3 gene polymorphism associated with Parkinson's disease. Neuroscience Letters, 414 (2), 126-9. doi:10.1016/j.neulet.2006.12.053 ![]() |
Riess, O., Krüger, R., Hochstrasser, H., Soehn, A. S., Nuber, S., Franck, T., & Berg, D. (2006). Genetic causes of Parkinson's disease: extending the pathway. Journal of Neural Transmission. Supplementum, (70), 181-9. doi:10.1007/978-3-211-45295-0_29 ![]() |
Maraganore, D. M., de Andrade, M., Elbaz, A., Farrer, M. J., Ioannidis, J. P., Krüger, R., Rocca, W. A., Schneider, N. K., Lesnick, T. G., Lincoln, S. J., Hulihan, M. M., Aasly, J. O., Ashizawa, T., Chartier-Harlin, M.-C., Checkoway, H., Ferrarese, C., Hadjigeorgiou, G., Hattori, N., Kawakami, H., ... Van Broeckhoven, C. (2006). Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease. JAMA: Journal of the American Medical Association, 296 (6), 661-70. doi:10.1001/jama.296.6.661 ![]() |
Elbaz, A., Nelson, L. M., Payami, H., Ioannidis, J. P. A., Fiske, B. K., Annesi, G., Carmine Belin, A., Factor, S. A., Ferrarese, C., Hadjigeorgiou, G. M., Higgins, D. S., Kawakami, H., Krüger, R., Marder, K. S., Mayeux, R. P., Mellick, G. D., Nutt, J. G., Ritz, B., Samii, A., ... Trikalinos, T. A. (2006). Lack of replication of thirteen single-nucleotide polymorphisms implicated in Parkinson's disease: a large-scale international study. Lancet Neurology, 5 (11), 917-23. doi:10.1016/S1474-4422(06)70579-8 ![]() |
Strauss, K. M., Martins, L., Plun-Favreau, H., Marx, F. P., Kautzmann, S., Berg, D., Gasser, T., Wszolek, Z., Muller, T., Bornemann, A., Wolburg, H., Downward, J., Riess, O., Schulz, J. B., & Krüger, R. (2005). Loss of function mutations in the gene encoding Omi/HtrA2 in Parkinson's disease. Human molecular genetics, 14 (15), 2099-111. doi:10.1093/hmg/ddi215 ![]() |
Hochstrasser, H., Tomiuk, J., Walter, U., Behnke, S., Spiegel, J., Krüger, R., Becker, G., Riess, O., & Berg, D. (2005). Functional relevance of ceruloplasmin mutations in Parkinson's disease. FASEB Journal, 19 (13), 1851-3. doi:10.1096/fj.04-3486fje ![]() |
Hofer, A., Berg, D., Asmus, F., Niwar, M., Ransmayr, G., Riemenschneider, M., Bonelli, S.-B., Steffelbauer, M., Ceballos-Baumann, A., Haussermann, P., Behnke, S., Krüger, R., Prestel, J., Sharma, M., Zimprich, A., Riess, O., & Gasser, T. (2005). The role of alpha-synuclein gene multiplications in early-onset Parkinson's disease and dementia with Lewy bodies. Journal of Neural Transmission, 112 (9), 1249-54. doi:10.1007/s00702-004-0263-3 ![]() |
Maraganore, D. M., Lesnick, T. G., Elbaz, A., Chartier-Harlin, M.-C., Gasser, T., Krüger, R., Hattori, N., Mellick, G. D., Quattrone, A., Satoh, J.-I., Toda, T., Wang, J., Ioannidis, J. P. A., de Andrade, M., & Rocca, W. A. (2004). UCHL1 is a Parkinson's disease susceptibility gene. Annals of neurology, 55 (4), 512-21. doi:10.1002/ana.20017 ![]() |
Glass, A. S., Huynh, D. P., Franck, T., Woitalla, D., Muller, T., Pulst, S. M., Berg, D., Krüger, R., & Riess, O. (2004). Screening for mutations in synaptotagmin XI in Parkinson's disease. Journal of Neural Transmission. Supplementum, (68), 21-8. doi:10.1007/978-3-7091-0579-5_3 ![]() |
Krüger, R. (2004). Genes in familial parkinsonism and their role in sporadic Parkinson's disease. Journal of Neurology, 251 Suppl 6, 2-6. doi:10.1007/s00415-004-1602-x ![]() |
Storch, A., Hofer, A., Krüger, R., Schulz, J. B., Winkler, J., & Gerlach, M. (2004). New developments in diagnosis and treatment of Parkinson's disease--from basic science to clinical applications. Journal of Neurology, 251 Suppl 6, 33-8. doi:10.1007/s00415-004-1608-4 ![]() |
Hering, R., Petrovic, S., Mietz, E.-M., Holzmann, C., Berg, D., Bauer, P., Woitalla, D., Muller, T., Berger, K., Krüger, R., & Riess, O. (2004). Extended mutation analysis and association studies of Nurr1 (NR4A2) in Parkinson disease. Neurology, 62 (7), 1231-2. doi:10.1212/01.WNL.0000118285.18383.90 ![]() |
Hering, R., Strauss, K. M., Tao, X., Bauer, A., Woitalla, D., Mietz, E.-M., Petrovic, S., Bauer, P., Schaible, W., Muller, T., Schols, L., Klein, C., Berg, D., Meyer, P. T., Schulz, J. B., Wollnik, B., Tong, L., Krüger, R., & Riess, O. (2004). Novel homozygous p.E64D mutation in DJ1 in early onset Parkinson disease (PARK7). Human Mutation, 24 (4), 321-9. doi:10.1002/humu.20089 ![]() |
Krüger, R. (2004). The role of synphilin-1 in synaptic function and protein degradation. Cell and Tissue Research, 318 (1), 195-9. doi:10.1007/s00441-004-0953-z ![]() |
Muller, T., Przuntek, H., Krüger, R., & Mackowiak, A. (2004). Antiapoptotic effects of budipine. Journal of Neural Transmission, 111 (10-11), 1365-73. doi:10.1007/s00702-004-0157-4 ![]() |
Kobayashi, H., Krüger, R., Markopoulou, K., Wszolek, Z., Chase, B., Taka, H., Mineki, R., Murayama, K., Riess, O., Mizuno, Y., & Hattori, N. (2003). Haploinsufficiency at the alpha-synuclein gene underlies phenotypic severity in familial Parkinson's disease. Brain : a journal of neurology, 126 (Pt 1), 32-42. doi:10.1093/brain/awg010 ![]() |
Marx, F. P., Holzmann, C., Strauss, K. M., Li, L., Eberhardt, O., Gerhardt, E., Cookson, M. R., Hernandez, D., Farrer, M. J., Kachergus, J., Engelender, S., Ross, C. A., Berger, K., Schols, L., Schulz, J. B., Riess, O., & Krüger, R. (2003). Identification and functional characterization of a novel R621C mutation in the synphilin-1 gene in Parkinson's disease. Human molecular genetics, 12 (11), 1223-31. doi:10.1093/hmg/ddg134 ![]() |
Thiex, R., Krüger, R., Friese, S., Gronewaller, E., & Kuker, W. (2003). Giant cavernoma of the brain stem: value of delayed MR imaging after contrast injection. European Radiology, 13 Suppl 6, 219-25. doi:10.1007/s00330-002-1772-9 ![]() |
Riess, O., Berg, D., Krüger, R., & Schulz, J. B. (2003). Therapeutic strategies for Parkinson's disease based on data derived from genetic research. Journal of Neurology, 250 Suppl 1, 3-10. doi:10.1007/s00415-003-1101-3 ![]() |
Schulte, T., Bohringer, S., Schols, L., Muller, T., Fischer, C., Riess, O., Przuntek, H., Berger, K., Epplen, J. T., & Krüger, R. (2003). Modulation of disease risk according to a cathepsin D / apolipoprotein E genotype in Parkinson's disease. Journal of Neural Transmission, 110 (7), 749-55. doi:10.1007/s00702-003-0832-x ![]() |
Holzmann, C., Krüger, R., Saecker, A. M. M. V., Schmitt, I., Schols, L., Berger, K., & Riess, O. (2003). Polymorphisms of the alpha-synuclein promoter: expression analyses and association studies in Parkinson's disease. Journal of Neural Transmission, 110 (1), 67-76. doi:10.1007/s00702-002-0769-5 ![]() |
Krüger, R., Fischer, C., Schulte, T., Strauss, K. M., Muller, T., Woitalla, D., Berg, D., Hungs, M., Gobbele, R., Berger, K., Epplen, J. T., Riess, O., & Schols, L. (2003). Mutation analysis of the neurofilament M gene in Parkinson's disease. Neuroscience Letters, 351 (2), 125-9. doi:10.1016/S0304-3940(03)00903-0 ![]() |
Krüger, R., Eberhardt, O., Riess, O., & Schulz, J. B. (2002). Parkinson's disease: one biochemical pathway to fit all genes? Trends in Molecular Medicine, 8 (5), 236-40. doi:10.1016/S1471-4914(02)02333-X ![]() |
Rahner, N., Holzmann, C., Krüger, R., Schols, L., Berger, K., & Riess, O. (2002). Neurofilament L gene is not a genetic factor of sporadic and familial Parkinson's disease. Brain research, 951 (1), 82-6. doi:10.1016/S0006-8993(02)03138-4 ![]() |
Riess, O., Krüger, R., & Schulz, J. B. (2002). Spectrum of phenotypes and genotypes in Parkinson's disease. Journal of Neurology, 249 Suppl 3, 15-20. doi:10.1007/s00415-002-1303-2 ![]() |
Ubl, A., Berg, D., Holzmann, C., Krüger, R., Berger, K., Arzberger, T., Bornemann, A., & Riess, O. (2002). 14-3-3 protein is a component of Lewy bodies in Parkinson's disease-mutation analysis and association studies of 14-3-3 eta. Molecular Brain Research, 108 (1-2), 33-9. doi:10.1016/S0169-328X(02)00510-7 ![]() |
![]() ![]() | Wintermeyer, P., Riess, O., Schols, L., Przuntek, H., Miterski, B., Epplen, J. T., & Krüger, R. (2002). Mutation analysis and association studies of nuclear factor-kappaB1 in sporadic Parkinson's disease patients. Journal of Neural Transmission, 109 (9), 1181-8. doi:10.1007/s00702-001-0688-x ![]() |
Schulte, T., Schols, L., Muller, T., Woitalla, D., Berger, K., & Krüger, R. (2002). Polymorphisms in the interleukin-1 alpha and beta genes and the risk for Parkinson's disease. Neuroscience Letters, 326 (1), 70-2. doi:10.1016/S0304-3940(02)00301-4 ![]() |
Krüger, R., Kuhn, W., Leenders, K. L., Sprengelmeyer, R., Muller, T., Woitalla, D., Portman, A. T., Maguire, R. P., Veenma, L., Schroder, U., Schols, L., Epplen, J. T., Riess, O., & Przuntek, H. (2001). Familial parkinsonism with synuclein pathology: clinical and PET studies of A30P mutation carriers. Neurology, 56 (10), 1355-62. doi:10.1212/WNL.56.10.1355 ![]() |
Krüger, R., Schols, L., Muller, T., Kuhn, W., Woitalla, D., Przuntek, H., Epplen, J. T., & Riess, O. (2001). Evaluation of the gamma-synuclein gene in German Parkinson's disease patients. Neuroscience Letters, 310 (2-3), 191-3. doi:10.1016/S0304-3940(01)02127-9 ![]() |
Schols, L., Peters, S., Szymanski, S., Krüger, R., Lange, S., Hardt, C., Riess, O., & Przuntek, H. (2000). Extrapyramidal motor signs in degenerative ataxias. Archives of neurology, 57 (10), 1495-500. doi:10.1001/archneur.57.10.1495 ![]() |
Miterski, B., Krüger, R., Wintermeyer, P., & Epplen, J. T. (2000). PCR/SSCP detects reliably and efficiently DNA sequence variations in large scale screening projects. Combinatorial chemistry & high throughput screening, 3 (3), 211-8. doi:10.2174/1386207003331607 ![]() |
Krüger, R., Menezes-Saecker, A. M., Schols, L., Kuhn, W., Muller, T., Woitalla, D., Berg, D., Berger, K., Przuntek, H., Epplen, J. T., & Riess, O. (2000). Genetic analysis of the alpha2-macroglobulin gene in early- and late-onset Parkinson's disease. Neuroreport, 11 (11), 2439-42. doi:10.1097/00001756-200008030-00020 ![]() |
Riess, O., Kuhn, W., & Krüger, R. (2000). Genetic influence on the development of Parkinson's disease. Journal of Neurology, 247 Suppl 2, 69-74. ![]() |
Wintermeyer, P., Krüger, R., Kuhn, W., Muller, T., Woitalla, D., Berg, D., Leroy, E., Polymeropoulos, M., Berger, K., Przuntek, H., Schols, L., Epplen, J. T., & Riess, O. (2000). Mutation analysis and association studies of the UCHL1 gene in German Parkinson's disease patients. Neuroreport, 11 (10), 2079-82. doi:10.1097/00001756-200007140-00004 ![]() |
Krüger, R., Hardt, C., Tschentscher, F., Jackel, S., Kuhn, W., Muller, T., Werner, J., Woitalla, D., Berg, D., Kuhnl, N., Fuchs, G. A., Santos, E. J., Przuntek, H., Epplen, J. T., Schols, L., & Riess, O. (2000). Genetic analysis of immunomodulating factors in sporadic Parkinson's disease. Journal of Neural Transmission, 107 (5), 553-62. doi:10.1007/s007020070078 ![]() |
Krüger, R., Muller, T., & Riess, O. (2000). Involvement of alpha-synuclein in Parkinson's disease and other neurodegenerative disorders. Journal of Neural Transmission, 107 (1), 31-40. doi:10.1007/s007020050002 ![]() |
Krüger, R., Vieira-Saecker, A. M., Kuhn, W., Berg, D., Muller, T., Kuhnl, N., Fuchs, G. A., Storch, A., Hungs, M., Woitalla, D., Przuntek, H., Epplen, J. T., Schols, L., & Riess, O. (1999). Increased susceptibility to sporadic Parkinson's disease by a certain combined alpha-synuclein/apolipoprotein E genotype. Annals of neurology, 45 (5), 611-7. doi:10.1002/1531-8249(199905)45:5<611::AID-ANA9>3.0.CO;2-X ![]() |
Grasbon-Frodl, E. M., Egensperger, R., Kosel, S., Krüger, R., Riess, O., Mehraein, P., & Graeber, M. B. (1999). The alpha1-antichymotrypsin A-allele in German Parkinson disease patients. Journal of Neural Transmission, 106 (7-8), 729-36. doi:10.1007/s007020050193 ![]() |
Krüger, R., Vieira-Sacker, A. M., Kuhn, W., Muller, T., Woitalla, D., Schols, L., Przuntek, H., Epplen, J. T., & Riess, O. (1999). Analysis of the parkin deletion in sporadic and familial Parkinson's disease. Short communication. Journal of Neural Transmission, 106 (2), 159-63. doi:10.1007/s007020050148 ![]() |
Schols, L., Krüger, R., Amoiridis, G., Przuntek, H., Epplen, J. T., & Riess, O. (1998). Spinocerebellar ataxia type 6: genotype and phenotype in German kindreds. Journal of neurology, neurosurgery, and psychiatry, 64 (1), 67-73. doi:10.1136/jnnp.64.1.67 ![]() |
Muller, T., Kuhn, W., Krüger, R., & Przuntek, H. (1998). Selegiline as immunostimulant--a novel mechanism of action? Journal of Neural Transmission. Supplementum, 52, 321-8. doi:10.1007/978-3-7091-6499-0_33 ![]() |
Krüger, R., Kuhn, W., Muller, T., Woitalla, D., Graeber, M., Kosel, S., Przuntek, H., Epplen, J. T., Schols, L., & Riess, O. (1998). Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nature genetics, 18 (2), 106-8. doi:10.1038/ng0298-106 ![]() |
Riess, O., Jakes, R., & Krüger, R. (1998). Genetic dissection of familial Parkinson's disease. Molecular Medicine Today, 4 (10), 438-44. doi:10.1016/S1357-4310(98)01343-4 ![]() |
Wilfried, K., Muller, T., Krüger, R., & Horst, P. (1996). Selegiline stimulates biosynthesis of cytokines interleukin-1 beta and interleukin-6. Neuroreport, 7 (18), 2847-8. doi:10.1097/00001756-199611250-00007 ![]() |